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INTRODUCTION
Until the 1960s, protein secretion through biological mem-
branes was thought to be a relatively rare phenomenon. Fur-
thermore, this view was governed by the assumption that where
a protein was secreted it crossed the membrane via its own
dedicated and specific mechanism. In the intervening years this
view has radically changed, with the growing realization that
both prokaryotic and eukaryotic cells secrete a prodigious ar-
ray of proteins and possess protein translocation pathways
which are surprisingly conserved throughout the phylogenetic
kingdoms.
A surprising amount of information regarding bacterial pro-
tein secretion has been derived from the study of bacterial
pathogenesis. Indeed, molecular and genetic investigations of
bacteria have shown that pathogenic organisms may be differ-
entiated from their nonpathogenic counterparts by the pres-
ence of genes encoding specific virulence determinants and
that those proteinaceous virulence determinants, in the form
of adhesins, toxins, enzymes, and mediators of motility, are
usually secreted to or beyond the bacterial cell surface (139).
Thus, by decorating their cell surfaces with such proteins,
pathogens can directly or indirectly increase their ability to
survive and multiply in the host. However, a facet often ig-
nored by those studying bacterial pathogenesis and protein
secretion is that many nonpathogenic organisms also secrete
proteins which are adaptive to their life-styles; e.g., saprophytic
bacteria may secrete cellulases or other degradative enzymes.
However, in both cases, secretion of these factors is governed
in large part by the structure of the bacterial cell envelope.
Gram-positive bacteria produce a single plasma membrane,
the cytoplasmic membrane, followed by a thick cell wall layer.
In contrast, gram-negative bacteria produce a double-mem-
brane system consisting of a cytoplasmic membrane, also called
the inner membrane, and an outer membrane which sandwich
the peptidoglycan and periplasmic space between them. Pro-
tein secretion across the inner membrane of both gram-posi-
tive and gram-negative organisms generally follows the same
routes, normally involving the Sec-dependent pathway (often
referred to as the general secretory pathway [GSP]), although
other routes have recently been identified, e.g., the Tat and
signal recognition particle (SRP) pathways (96, 109, 116, 119,
208, 338, 419, 434). However, once across the inner membrane,
the fate of the translocated proteins diverge. In gram-positive
organisms, the proteins are either released into the extracel-
lular environment or incorporated into the cell wall layer by
virtue of one of several cell wall peptide-anchoring mecha-
nisms (78, 319). In contrast, translocation across the gram-
negative inner membrane results in release of the protein into
the periplasmic space. Thus, proteins that are targeted for the
cell surface or extracellular milieu must also cross the addi-
tional barrier to secretion formed by the outer membrane. To
achieve translocation of these proteins to the cell surface and
beyond, gram-negative bacteria have evolved several dedicated
secretion systems, some of which bypass the Sec-dependent
system and integrate both inner and outer membrane transport
in a temporally linked fashion (see below).
In this review, we comprehensively describe the autotrans-
porter secretion pathway, which is present in gram-negative
organisms including animal and plant pathogens. We examine
the roles of these proteins in the context of bacterial patho-
genesis and highlight areas for future research. Readers are
referred to more concise reviews of the autotransporter secre-
tion pathway (101, 102, 203) and the roles of these proteins in
pathogenesis (201).
SECRETION BY NUMBERS: PROTEIN SECRETION
MECHANISMS IN GRAM-NEGATIVE BACTERIA
Recent progress in the molecular analysis of the protein
secretion pathways of gram-negative bacteria has revealed the
existence of at least five major mechanisms of protein secre-
tion. These pathways are highly conserved throughout the
gram-negative bacterial species and are functionally indepen-
dent mechanisms with respect to outer membrane transloca-
tion; commonalities exist in the inner membrane transport
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steps of some systems. For better or worse, these pathways
have been numbered type I, II, III, IV, and V. Several more
extensive reviews of the gram-negative protein secretion sys-
tems have recently been published (4, 32, 64, 66, 147, 156, 264,
274, 294, 377, 395, 428, 429). Figure 1 gives an overview of the
Type I, II, III and IV secretion pathways.
At this juncture, it is worth noting that some confusion has
existed in the literature regarding the nomenclature of the type
IV and type V protein secretion pathways. Almost simulta-
neously, the type IV nomenclature appeared in several articles
referring to both the autotransporter secretion pathway and
the family of pathways exemplified by Agrobacterium tumefa-
ciens T-DNA secretion. However, this matter has recently been
resolved, with a consensus reached on the nomenclature of the
pathways (160, 202). Thus, the A. tumefaciens and similar se-
cretion pathways have retained the type IV terminology and
the pathway used by the autotransporter and similar proteins
has been termed the type V secretion system.
Type I Protein Secretion
The prototypical example of the type I secretion system
(TOSS) is that required for secretion of Escherichia coli alpha-
hemolysin (HlyA) (156). HlyA is a lipid modified protein with
a repetitive domain composed of 11 to 17 9-amino-acid repeats
which bind calcium and are thought to interact with host cells.
This interaction stimulates the insertion of HlyA into the
plasma membrane of eukaryotic cells, causing pore formation
and release of the cytoplasmic contents. Other well-studied
members of this group include the metalloprotease of Erwinia
chrysanthemi (32, 160), the leukotoxin of Pasteurella haemo-
lytica (345), and the adenylate cyclase of Bordetella pertussis
(272).
Secretion of HlyA, and similar effector molecules, occurs in
a Sec-independent manner and in a continuous process across
both the inner and outer membranes. Furthermore, proteins
secreted by TOSSs are not processed during secretion and do
FIG. 1. Schematic representation of the type I, II, III, and IV protein secretion systems. The type I pathway is exemplified by hemolysin A
(HlyA) secretion in E. coli, the type III system is exemplified by Yop secretion in Yersinia, the type II system is exemplified by pullulanase secretion
in Klebsiella oxytoca, and the type IV system is exemplified by the VirB system in A. tumefaciens. ATP hydrolysis by HlyB, YscN, SecA, and VirB11
is indicated. Secreted effector molecules are depicted as grey ovals. The type II and in some cases the type IV secretion systems utilize the
cytoplasmic chaperone SecB, although the Tat export pathway has recently been implicated in the secretion of molecules via the type II pathway.
Type III secretion also involves cytoplasmic chaperones (SycE); however, they do not interact with the Sec inner membrane translocon. The major
structural proteins of each system are depicted in relation to their known or deduced position in the cell envelope. EM, extracellular milieu; OM,
outer membrane; Peri, periplasm; IM, inner membrane; Cyto, cytoplasm.
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not form distinct periplasmic intermediates. Rather, the TOSS
consists of three proteins: a pore-forming outer membrane
protein, a membrane fusion protein (MFP), and an inner
membrane ATP-binding cassette (ABC) protein (32). These
proteins are represented in E. coli by TolC, HlyD and HlyB,
respectively. Evidence suggests that the MFP (HlyD) and the
ABC transporter (HlyB) in E. coli interact before binding of
the effector (156). The secretion process begins when a secre-
tion signal located within the C-terminal end of the secreted
effector molecule interacts with the ABC transporter protein
(224). In general, this signal sequence is specific and is recog-
nized only by the dedicated ABC transporter. Once binding of
the effector molecule occurs, interaction of HlyD with the
outer membrane protein TolC is triggered, allowing secretion
of the effector molecule to he external milieu (450). However,
this model is somewhat controversial, since investigation of the
E. chrysanthemi TOSS indicates that the ABC transporter and
MFP interact only after binding of the effector molecule and
subsequently MFP interacts with the pore-forming outer mem-
brane protein (282). Nevertheless, it is apparent that in both
cases the bridging formed by MFP and the outer membrane
protein collapses after export of the effector molecule (485).
ATP hydrolysis by the ABC transporter provides the impetus
to drive secretion of the effector molecule across the cell en-
velope to the external milieu once bridging of all molecules has
occurred. Hydrolysis of ATP is not required for interaction of
the effector with the ABC protein or assembly of the TOSS
complex (261, 262).
Recent data have indicated a possible structure for the
TOSS complex. Resolution of the crystal structure demon-
strated that TolC exists as a trimer and that the portion span-
ning the outer membrane formed a -barrel structure (Fig. 2)
(263). However, unlike the typical porins, each monomer of
TolC contributes four -strands to form a 12-strand antipar-
allel -barrel. In addition to forming the -barrel structure,
TolC possesses a novel protein structure: the -helical barrel.
This extends from the integral outer membrane -barrel struc-
ture into the periplasm (263). HlyD is also known to form a
trimeric structure which projects from the inner membrane
into the periplasm. Thus, it is easy to envisage a scenario where
the monomers of HlyD and TolC, while forming their trimeric
complexes, can extend to form a continuous channel across the
inner and outer membranes at the appropriate time. Never-
theless, further investigations are required to fully appreciate
the roles of each protein in the TOSS.
Two-Step Type II Protein Secretion
The type II secretion pathway is often referred to as the
main terminal branch (MTB) of the Sec-dependent GSP (428).
The subunits of a type II secretion pathway identified in E. coli
have been designated GspA to GspO (146). Unfortunately,
this has served to confuse the general reader about the no-
menclature of the type II secretion pathway and the GSP
(100). Thus, it must be stressed here that type II secretion does
not refer to the GSP in general but refers only to one of several
branches, as described below. Recently, it has been suggested
that the pathway be renamed the secreton-dependent pathway
(516).
Secretion via the MTB is exemplified by pullulanase (PulA)
secretion from Klebsiella oxytoca (478, 57). PulA is a starch-
hydrolyzing lipoprotein which forms micelles once it has been
secreted into the external environment (478). Since the discov-
ery of the MTB in K. oxytoca, the pathway has been identified
in a variety of other bacterial species exporting a range of
proteins with diverse functions including the cholera toxin of
Vibrio cholerae, exotoxin A of P. aeruginosa, and several cell
wall-degrading enzymes (428, 429). Furthermore, analyses of
the MTBs and type IV fimbrial systems at the genetic and
structural levels have shown sufficient similarity between the
two systems to suggest that the fimbrial biogenesis pathway be
classed as a type II secretion pathway (34).
Secretion of substrate proteins via the MTB occurs in a
two-step Sec-dependent fashion. Thus, all proteins secreted via
a type II secretion pathway are synthesized with an N-terminal
FIG. 2. Structure of TolC. The structure of TolC was solved to
2.1-A˚ resolution. The functional TolC unit consists of three TolC mon-
omers oligomerized into a regular structure embedded in the outer
membrane and extending into the periplasm such that it forms a
continuous solvent-accessible conduit. The portion of the trimeric mol-
ecule that is embedded in the outer membrane adopts a 12-strand
-barrel conformation consisting of four -strands per monomer. The
molecule is 140 A˚ long, the -barrel is 40 A˚ long (spanning the outer
membrane), and the remaining portion of the molecule adopts a 100 A˚
-helical conformation spanning the periplasmic space. This -helical
domain consists of 12 -helices, such that the -helices extend from or
connect to the periplasmic side of each -strand. It is the -helical
domain that is predicted to interact with the MFP. Each monomer is
highlighted in a separate color. Adapted from reference 263 and the
Protein Data Bank (30).
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signal sequence which targets proteins for secretion to the Sec
inner membrane secretion pathway (for in-depth reviews, see
references 115; 245; and 509). The Sec machinery is composed
of an ATPase, SecA, several integral inner membrane proteins
(SecD, SecE, SecF, SecG, and SecY, and a signal peptidase
(116, 338). SecB, a cytoplasmic chaperone, does not recognize
the signal sequence but recognizes the mature part of the
protein targeted for secretion and subsequently directs the
protein to the Sec translocon (109). SecA provides the energy
for transport through the translocon, and the signal peptidase
cleaves the signal sequence, releasing the remainder of the
protein into the periplasm. Evidence suggests that, once in the
periplasm the remaining protein adopts a quasi-native state
which is facilitated by certain chaperones such as disulfide
bond isomerase, DsbA (486). These folding steps are necessary
for translocation across the outer membrane.
Transport across the outer membrane requires an additional
12 to 16 accessory proteins, which are collectively referred to as
the secreton (428, 429, 486). A consensus nomenclature has
been defined by the letters A to O and S for homologous genes
and their products (the Xcp proteins of P. aeruginosa are la-
belled P to Z). The organization of the loci encoding the MTB
components is relatively conserved, and most of the genes are
transcribed from a single operon in which several of the genes
are overlapping (428, 429). Evidence from both the Klebsiella
Pul system and the Erwinia Out system for pectinase secretion
suggests that protein C contributes to a species-specific inter-
action defining the transport of specific substrate proteins (42,
290, 404, 405). Protein D belongs to a family of proteins
termed secretins. These proteins are integral outer membrane
proteins predicted to consist largely of transmembrane
-strands and form a -barrel structure in the outer mem-
brane, with 12 to 14 subunits forming a complex (34, 188, 257).
Several possible configurations for the secretin complex have
been proposed. The most popular of these include a complex
where monomers of protein D oligomerize to form a ring with
a central channel and a model reminiscent of the TolC struc-
ture, where each monomer contributes -strands to form a
single central channel (486). The C-terminal region is con-
served among the secretins and is thought to be embedded in
the outer membrane. It is interesting that homologues of the
protein D secretin proteins have been found in the type III
secretion pathways (see below) (486). Evidence suggests that
protein E may act as a kinase regulating the secretion process
by supplying energy to promote translocation and assembly of
the pilin-like subunits, proteins G to K (430). No protein-
protein interactions have been demonstrated for protein F
(488). Proteins G to K possess homology to the type IV pili and
are thought to form a pseudopilus (112, 264). Furthermore,
these proteins are N-terminally processed and methylated by a
prepilin peptidase, protein O (36, 390). A lipoprotein, protein
S, has been demonstrated to play a role in stabilization of the
outer membrane component protein D (428). Several other
accessory proteins, which are not present in all MTB pathways,
have a demonstrated requirement for substrate secretion in
certain MTB systems. Evidence suggests that this may be re-
lated to the type of proteins being secreted or to substrate
recognition by the MTB. In summary, the available evidence
indicates that most if not all of the components of an MTB
interact to form a multiprotein complex spanning both the
inner and outer membranes (Fig. 1). Many more comprehen-
sive reviews are available which describe the structure and
function of the components of the MTB (428, 429).
The Injectisome: Type III Protein Secretion
The archetypal type III secretion system (TTSS) was first
identified in pathogenic Yersinia spp. for the secretion of Yop
proteins (326). Since this discovery, TTSS have been identified
in several mammalian and plant pathogens including Salmo-
nella enterica, Shigella flexneri, E. coli, Ralstonia solancearum,
Pseudomonas syringae, and Chlamydia trachomatis (214, 395).
Recently, TTSS have been the subject of considerable interest
because of their primary role in the virulence of these animal
and plant pathogens. Interestingly, detailed investigations have
shown that TTSS and the gram-negative flagellar export appa-
ratus are homologous, leading some investigators to classify
the flagellar biosynthesis pathway as a TTSS (37, 307). Thus,
while the mechanism for secretion of effector molecules is
highly conserved in the TTSS, the effector molecules them-
selves are divergent and perform a variety of functions. Read-
ers are referred to more in-depth reviews of the structure and
function of TTSS, which cover the voluminous research avail-
able (4, 37, 64, 214, 307, 395).
Genes encoding components required for TTSS are gener-
ally located on a single plasmid or chromosomal locus. Com-
parison of the sequences demonstrates that the genes at these
loci are conserved among different species, suggesting that
these loci are inherited as a distinct genetic unit and that a
common mechanism exists for the recognition and secretion of
effector molecules (4, 64, 294, 395).
Like the TOSS, the TTSS translocate their effector mole-
cules across the inner and outer membranes in a Sec-indepen-
dent fashion. However, it is important to note that the Sec
translocon, as in the case of TOSS, is required for secretion of
structural components across the inner membrane. Contro-
versy exists about the mechanism of effector molecule recog-
nition and targeting to the TTSS. One hypothesis suggests
that the signal resides in the 5 mRNA, which may target the
ribosome-RNA complex to the TTSS, permitting temporal
coupling of translation and secretion (11). A second proposal
suggests that the N-terminal 20 amino acids serve as a binding
site for cytoplasmic chaperones which specifically target the
effector molecules to the TTSS (295). Notwithstanding the
differences in these hypotheses, it is apparent that the region
encoding the first 20 amino acids (either the untranslated
mRNA or the first 20 amino acids of the polypeptide) is es-
sential for secretion and the process is highly regulated (214).
Once targeted to the cytoplasmic side of the TTSS, secretion
of the effector molecule may occur without the formation of
periplasmic intermediates, with secretion proceeding through
a needle-like structure composed of approximately 20 different
proteins (214, 269). Unfortunately, a description of the volu-
minous evidence to support the roles of specific proteins in the
formation of the TTSS complex is beyond the scope of this
review. Based on the current evidence, the placement of spe-
cific proteins in the TTSS complex is indicated in Fig. 1. How-
ever, it is worth reiterating that the TTSS possesses a secretin-
like component homologous to those found in the MTB
systems (486). This secretin-like protein has been demon-
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strated to form ring-shaped structures with large central pores,
which facilitates secretion of effector molecules and stabilizes
the needle-like complex formed by the other components of
the TTSS (153). This complex spans both the inner and outer
membranes, resembling a hypodermic needle. The formation
of a needle-like structure is supported by the visualization of
the S. enterica and S. flexneri TTSS by electron microscopy
(269). These studies demonstrated a striking resemblance be-
tween the TTSS and the flagellar basal body, and since the
TTSS were shown to form long pilus-like structures, it was
assumed, through analogy to the flagellar system, that the pilus
structure allows protein transport across the bacterial outer
membrane to the external milieu (214, 307). This was sup-
ported by investigations showing structural and sequence sim-
ilarities between the EspA pilus protein of the E. coli TTSS
and the flagellar filament (89, 255).
Perhaps the most striking feature of TTSS is their ability to
target effector proteins directly into eukaryotic cells. This phe-
nomenon is triggered in some cases when the bacterium comes
in contact with a eukaryotic cell; hence, secretion via the type
III pathway has been termed “contact dependent” (545). The
analogy between the TTSS and the hypodermic syringe, cou-
pled with the ability of the systems to inject proteins directly
into the host cytosol, has allowed the phrase “injectisome” to
be coined for this protein secretion system. Nevertheless, in-
vestigators should be reminded that not all TTSS are contact
dependent and some effector molecules secreted by TTSS are
released into the external environment (75).
Type IV Protein and Nucleoprotein Secretion
The type IV protein secretion system (TFSS) is the least well
understood gram-negative protein secretion pathway. The sys-
tem is ancestrally related to the bacterial conjugation machin-
ery, although some controversy exists over which system comes
first on the evolutionary ladder. Nevertheless, it is clear that,
like the TTSS, the unifying characteristic of the TFSS and the
conjugative machinery is the ability to translocate protein mol-
ecules intercellularly, i.e., from one bacterium to another or
from a bacterium to a eukaryotic host cell. The prototypical
TFSS is that of the A. tumefaciens nucleoprotein T-DNA trans-
fer system. However, several other systems, which are required
for the full virulence of pathogenic bacteria, have been de-
scribed, including the B. pertussis Ptl (pertussis toxin) system
(130), the Dot/Icm system of Legionella pneumophila (546),
and those of Brucella suis (41), Bartonella henselae (443), and
Helicobacter pylori (18). Representatives of the conjugal DNA
transfer systems include the IncF, IncP, and IncW plasmid
transfer systems (Tra) (277). Thus, despite being a relatively
poorly understood protein secretion system, the TFSS has
been studied over several generations of researchers through
its analogies to the Tra systems.
As in other secretion pathways, the effector molecules se-
creted by the TFSS have a wide variety of functions. Arguably,
the best-characterized function is that of pertussis toxin, which
belongs to the A-B5 toxin family (130, 481). Unlike the other
type IV systems, the pertussis toxin is secreted to the extracel-
lular milieu rather than directly into a host cell (481). The B
domain (subunits S2 to S5) interacts with the host cell glyco-
protein receptors and mediates translocation of the A domain
(subunit S1) into the host cytosol. Once in the cytosol, the S1
subunit ribosylates the  subunits of G-proteins, interfering
with signaling pathways (310). In contrast, the A. tumefaciens
system secretes several effector molecules, VirD2, VirE2, and
VirF, into the host cell cytosol (67, 212). VirD2 is secreted as
a nucleoprotein complex; the protein remains covalently asso-
ciated with a single-stranded copy of T-DNA (266). Once in
the host cytosol, VirE2 interacts with the VirD2/T-DNA com-
plex, mediating delivery of the T-DNA to the host cell nucleus
and resulting in crown gall tumor formation. A role for the
VirF protein has yet to be defined conclusively. Unlike the
pertussis toxin, the Vir effector proteins are secreted separately
through the TFSS.
Controversy exists over how the substrate molecules for
TFSS pass through the inner membrane. For the A. tumefa-
ciens protein-DNA complex, export is postulated to take place
in a single continuous step from cytoplasm to the interior of
the cell. In contrast, export of pertussis toxin, like the type II
secretion pathway effector molecules, occurs in two steps; the
toxin subunits are first translocated across the inner membrane
via the Sec machinery and are subsequently targeted for export
across the outer membrane (51, 52). Thus, one evolutionary
branch of the TFSS appears to be a branch of the GSP whereas
the division encompassing T-DNA transfer is not.
The process governing transfer across the outer membrane
is best understood for the A. tumefaciens TFSS. The quantity of
information to support the individual roles of separate proteins
is too great to review here; however, it is worth mentioning the
roles of a few major proteins. Transfer of T-DNA and assem-
bly of the pilus requires VirA, VirB1 to VirB11, VirD1 to
VirD4, VirE2, and VirG. VirB2 is the major pilus subunit,
although it is not yet clear whether this pilus emanates from
the inner or outer membrane. VirB4 and VirB11 are inner
membrane proteins, and VirD4 is a cytoplasmic protein, all of
which possess ATPase activity. It has been suggested that these
proteins provide the energy for translocation of the effector
molecules through the pilus structure in a fashion analogous to
the TOSS and TTSS. The remaining proteins are variously
associated with the inner and outer membranes and with each
other; the proposed placement of each protein is indicated in
Fig. 1. TFSS has been divided into two subclasses: type IVa
corresponds to protein machinery containing VirB homo-
logues of A. tumefaciens, and type IVb corresponds to func-
tional secretion systems assembled from Tra homologues of
the Incl Collb-P9 plasmid of Shigella flexneri (66). Several ex-
cellent reviews have covered the functions of each subunit in
more detail (66, 111, 143, 274, 277, 448).
TYPE V PROTEIN SECRETION
Perhaps the simplest protein secretion mechanisms are
those which are included under the umbrella of type V secre-
tion. This family of secreted proteins includes those secreted
via the autotransporter system (type Va or AT-1), the two-
partner secretion pathway (type Vb), and the recently de-
scribed type Vc system (also temed AT-2) (99, 102). Proteins
secreted via these pathways have similarities in their primary
structures as well as striking similarities in their modes of
biogenesis. Figure 3 provides a schematic overview of the type
V secretion pathways.
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Autotransporter Secretion Pathway (Type Va)
Pohlner et al. (401) were the first to describe and propose a
model for type V secretion, elegantly elucidating the relation-
ship between the gene encoding the gonococcal immunoglob-
ulin A1 (IgA1) protease and its extracellular product. Thus,
the DNA sequence of a cloned fragment (4.6 kb) revealed a
single gene coding for a 169-kDa precursor of IgA1 protease;
the precursor contained three functional domains: the N-ter-
minal leader (which is assumed to initiate the inner membrane
transport of the precursor), the extracellular IgA1 protease,
and a C-terminal “helper” domain (which is required for se-
cretion across the outer membrane). In this seminal work, the
authors proposed a model in which the helper serves as a pore
for the secretion of the protease domain through the outer
membrane. IgA1 protease acquires an active conformation as
its extracellular transport proceeds and is released as a pro-
form from the membrane-bound helper by autoproteolysis.
The soluble proform matures further into the functional 106-
kDa IgA1 protease and a small stable -protein. It is possible
to find the active IgA1 protease in the culture medium from
iga-transformed E. coli and S. enterica (185, 253), supporting
the concept that the IgA1 protease precursor contains all the
necessary determinants to direct the translocation of the pro-
tease from the periplasm into the medium, without the partic-
ipation of accessory proteins (401). Since no energy coupling
or accessory factor seemed to be required for the translocation
process, and unlike the type I to IV systems, the molecules
targeted for secretion were strictly dedicated to their co-
valently linked cognate -domain, the proteins secreted in this
fashion received the name of autotransporters.
Since this initial description, many more proteins which fol-
low this pathway of secretion have been identified among the
FIG. 3. Schematic overview of the type V secretion systems. The secretion pathway of the autotransporter proteins (type Va) is depicted at the
bottom left of the diagram, the two-partner system (type Vb) is depicted in the center of the diagram, and the type Vc or AT-2 family is depicted
on the right. The four functional domains of the proteins are shown: the signal sequence, the passenger domain, the linker region, and the
-domain. The autotransporter polyproteins are synthesized and generally exported through the cytoplasmic membrane via the Sec machinery.
Interestingly, effector proteins with an unusual extended signal sequence, which purportedly mediates Srp-dependent export, are found in all three
categories of type V secretion. Once through the inner membrane, the signal sequence is cleaved and the -domain inserts into the outer
membrane in a biophysically favored -barrel structure that forms a pore in the outer membrane. After formation of the -barrel, the passenger
domain inserts into the pore and is translocated to the bacterial cell surface, where it may or may not undergo further processing.
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gram-negative bacteria (201). In all cases, the primary struc-
ture of the autotransporter protein is reminiscent of the
IgA1 protease, consisting of a modular structure composed of
three domains (231). These domains have been given different
names throughout the literature. In this review, we use a con-
sistent nomenclature throughout; thus, the domains are
termed the signal sequence, the passenger domain, and the
translocation unit. The signal sequence (also called the signal
peptide or leader sequence) is present at the N-terminal end of
the protein and allows targeting of the protein to the inner
membrane for its further export into the periplasm (203). The
next domain is the passenger domain (also called the -do-
main, N-passenger domain, or N-domain), which confers the
diverse effector functions of the various autotransporters. The
last main domain, located at the C-terminal end of the protein,
is the translocation unit (also called the -domain, helper do-
main, C-domain, transporter domain, or autotransporter do-
main), consisting of a short linker region with an -helical
secondary structure and a -core that adopts a -barrel tertiary
structure when embedded in the outer membrane (317, 364,
365, 475), facilitating translocation of the passenger domain
through the outer membrane.
Inner membrane transport. Bioinformatic analysis of the
gonococcal IgA1 protease N terminus using SignalP (352) pre-
dicts that this domain functions as a signal sequence, allowing
targeting of the protein to the inner membrane. Similarly, the
N-terminal regions of all other autotransporter proteins dis-
play characteristics of the prototypical Sec-dependent signal
sequence, for which SecB is presumed to act as the molecular
chaperone (45, 203). These signal sequences possess (i) an
n-domain with positively charged amino acids, (ii) an h-domain
containing hydrophobic amino acids, and (iii) a c-domain with
a consensus signal peptidase recognition site which often con-
tains helix-breaking proline and glycine residues as well as
uncharged and short lateral-chain residues at positions 3 and
1 that determine the site of signal sequence cleavage (315).
However, some autotransporters, like AIDA-1, Pet, or Hbp,
exhibit an unusually long signal sequence consisting of a C-
terminus resembling a normal signal sequence with a hydro-
phobic core and a consensus signal peptidase cleavage site but
presenting a conserved extension of the n-domain which con-
tributes most to the variation in overall length (203). In silico
analyses of completed bacterial genomes has revealed the pres-
ence of at least 80 proteins possessing these extended signal
sequences across the breadth of the Proteobacteria (Fig. 4) (M.
Desvaux and I. R. Henderson, unpublished observations). In-
terestingly, these extended signal sequences appear to be as-
sociated exclusively with proteins larger than 100 kDa. All of
these atypical signal sequences, consisting of at least 42 amino
acids, appear to consist of two charged domains (n1 and n2)
and two hydrophobic domains (h1 and h2), in addition to the
C-domain signal peptidase I recognition site (Fig. 4). While the
n1 and h1 domains of these autotransporters are well con-
served, the sequence of the n2 domain is variable and that of
the following h2 domain even more so (203). The variability
within the n2 and h2 domains is expected and consistent with
Sec-dependent signal sequences, although, notably, the n2 do-
main contains an unusual number of charged amino acids (49).
In contrast, the conservation within the n1 and h1 domains is
highly unusual and is characterized by the presence of con-
served aromatic amino acids in the n1 domain and a glutamate
residue in the h1 domain (Fig. 4). Such sequence conservation
is frequently indicative of the existence of a specialized biolog-
ical function, suggesting that the extended n1-h1 portion of the
signal sequence directs inner membrane export through a
pathway different from the Sec system or that it recruits acces-
sory proteins to work in tandem with the Sec pathway.
It was speculated that the features of those unusually long
signal sequences might serve to recruit accessory proteins, dif-
ferent from SecB, like the SRP, or to direct secretion via an
alternative pathway such as the Tat pathway (203). In E. coli,
protein export through the Sec translocon can use at least two
pathways: (i) the pathway involving the molecular chaperone
SecB, which keeps the preprotein in a translocation-competent
state and targets it to SecA (413), and (ii) the SRP pathway,
which permits a cotranslational translocation of the preprotein
by targeting the ribosome-SRP complex directly to the trans-
locon (208). Sijbrandi et al. (455) recently investigated the role
of this signal sequence in Hbp. It was demonstrated that
targeting and translocation through the inner membrane
involved the targeting factor SRP and the Sec translocon. SecB
was not required for the targeting of Hbp, but it could com-
pensate for the absence of a functional SRP pathway to some
extent. It was suggested that cotranslational translocation ver-
sus posttranslational translocation might prevent degradation
or premature folding of Hbp in the cytoplasm. This study
presents the first example of an extracellular protein targeted
by SRP; previously in gram-negative bacteria SRP was associ-
ated only with insertion of proteins into the inner membrane
(497). The authors speculated that the extended domain as a
whole, i.e., n1-h1, and the hydrophobic region in particular
might play an important role for the SRP recognition of the
signal sequence. In fact, crystal structure analysis of the SRP
has revealed an unusual RNA-protein interface that could
interact with the hydrophobic core of the signal sequence (20).
Controversially, the homologous EspP was found to be trans-
located across the inner membrane via the classical Sec path-
way (476). However, recent investigations have shown that the
truncated EspP signal sequence, i.e., Esp lacking n1-h1 do-
mains, fused to proteins normally targeted to the Sec appara-
tus by SecB leads to the rerouting of these proteins into the
SRP pathway; therefore, the role of the extended region n1-h1
in secretion remains enigmatic (391). Furthermore, no evi-
dence exists to support a role for this signal sequence in tar-
geting to the Tat pathway (455; I. R. Henderson et al., unpub-
lished observations) or for the involvement of other accessory
factors.
Interestingly, several recent reports have described auto-
transporter proteins, namely, the H. pylori AlpA, B. pertussis
SphB1, and N. meningitidis AspA/NalP proteins (82, 358, 508),
with typical lipoprotein signal sequences which are indicative
of processing by signal peptidase II. While investigations of
AlpA demonstrated that it was processed as a lipoprotein
when expressed in E. coli DH5, no such processing could be
demonstrated in wild-type H. pylori (358). An alternative hy-
pothesis is that AlpA is processed further downstream by sig-
nal peptidase I. Indeed, the protein may be acylated and pro-
cessed by signal peptidase II and may subsequently undergo
processing by signal peptidase I prior to insertion into the
outer membrane. Using a chimeric SphB1–-lactamase fusion,
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Coutte et al. (83) demonstrated that SphB1, like AlpA, was
processed as a lipoprotein in E. coli. However, such processing
could not be demonstrated directly in the natural B. pertussis
host. Nevertheless, growth in the presence of globomycin, a
specific inhibitor of signal peptidase II, prevented localization
of SphB1 in the outer membrane (83). Furthermore, the lo-
calization of AspA/NalP (also termed NalP) was also inhibited
by treatment with globomycin (508). Interestingly, the pres-
ence of the lipoprotein signal sequence was found to be nec-
essary for the functional localisation of SphB1 in the outer
membrane, suggesting that it is required for anchoring SphB1
on the bacterial cell surface (83).
Periplasmic transit. After export through the inner mem-
brane, the autotransporter proprotein exists as a periplasmic
intermediate. The original model of outer membrane secretion
predicts that the first of the -strands passes from the peri-
plasmic space to the external surface, thus leaving the passen-
ger domain temporarily extending into the periplasm (203).
Using a reporter single-chain antibody as a reporter passenger
domain, the secretion process has been investigated (510). It
was concluded that the folding of the passenger domain takes
place in the periplasm before, or at least simultaneously with
its own translocation through the outer membrane. However, a
recent investigation by Oliver et al. (365) revealed the presence
of an intramolecular chaperone in BrkA, spanned by residues
606 to 702. This region corresponds to PD002475 in the Pro-
Dom database (76) and is found in many autotransporters but
not in other proteins in the database. In the model derived
from this study, the complete folding of the protein occurs on
the surface of the bacteria (see the discussion of outer mem-
brane transport below). This suggests that previous findings by
Veiga et al. (510) may have been influenced by the study of a
passenger domain unrelated to the autotransporters. Further-
more, it is unlikely that large molecules, such as the passenger
domains, can pass through a pore of 2 nm while fully folded,
and therefore the molecules must be maintained in a translo-
cation-competent unfolded state in the periplasm.
Thus, the status of the autotransporter proteins in the peri-
plasm remains controversial. Of particular interest is how such
large proteins can maintain an unfolded, or partially folded,
state and resist degradation by periplasmic proteases. For
IcsA, the soluble periplasmic form of the autotransporter ap-
pears transient (46); hence, it was suggested that the -barrel
inserts rapidly into the outer membrane or may interact with
a general or autotransporter-specific periplasmic chaperone
(46). It was proposed that the chaperone activity of DegP was
involved (410). It is worth mentioning here that the formation
of disulfide bonds in the passenger domain in the presence
of the periplasmic disulfide bond-forming enzyme DsbA de-
creases the efficiency of secretion of the passenger domain (46,
232, 499, 510). This suggests that the proprotein is accessible to
periplasmic enzymes and that at least partial folding of the
autotransporter may arise in the periplasm. However, it re-
mains possible that the decrease in secretion efficiency is a
result of the translocation of a nonnative passenger domain
rather than the formation of disulfide bonds per se. Indeed, the
IcsA protein forms disulfide bonds in the periplasm and is
efficiently secreted via its native translocating unit (46). Nev-
ertheless, the paucity of cysteine residues which contribute to
disulfide bond formation is also a unifying characteristic of
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autotransporter passenger domains; thus, the secretion of pro-
teins with secondary structure appears to be an exception
rather than a rule (231).
-Domain. -Barrels can have different topologies; the sim-
plest of those theoretical topologies is the all-next-neighbor
connection between adjacent strands, in which each -strand
aligns in an antiparallel fashion to form a -sheet. The -barrel
architecture has been found in all integral outer membrane
proteins whose structures have been solved (97); -helical bun-
dles have been found only in the cytoplasmic membrane (257,
444). Generally, it is assumed that this differentiation origi-
nates from the biogenesis of the outer membrane proteins,
whose polypeptide chains have to cross the cytoplasmic mem-
brane, where, if they contained hydrophobic -helix-rich re-
gions, they would be stuck. As with all hitherto known integral
outer membrane proteins, the C-terminal domain of autotrans-
porter proteins is predicted to consist of -pleated sheets in the
form of a -barrel (303).
Generally, the C-terminal domains of autotransporters con-
sist of 250 to 300 amino acid residues. The -domain of auto-
transporters are all homologous but extremely diverse in se-
quence. Bioinformatic analyses of the C-terminal sequences of
highly diverse autotransporters have permitted a consensus
signature sequence to be proposed for this domain, which has
been proven useful for the identification of new autotransport-
ers from databases (203). While the exact shape of the -bar-
rels of various autotransporters is still subject to speculation,
some general features can be determined from bioinformatic
analysis. Using the AMPHI algorithm (223) or the WHAT and
AveHAS programs in combination (543, 544), it was predicted
that the -domains of most autotransporters exhibit 14 anti-
parallel amphipathic strands consisting of 9 to 12 residues (303,
540).
In addition to the overall -sheet structure, the -domains
share a consensus amino acid motif at the extreme C terminus,
which represents the final spanning segment (231, 303). The
terminal amino acid is always phenylalanine or tryptophan,
preceded by alternating hydrophilic (charged or polar) and
hydrophobic residues, i.e., (Y/V/I/F/W)-X-(F/W). This motif is
also found in other gram-negative outer membrane proteins; in
the case of PhoE, an E. coli porin, substitution or deletion of
the C-terminal phenylalanine has a drastic effect on protein
folding and stabilization of the monomer, resulting in an inef-
fective trimerization and outer membrane localization of the
protein (95, 470). This observation has also been extended to
the autotransporter proteins, since deletion of the final three
amino acid residues of the H. influenzae Hap autotransporter,
i.e., YSF, abolishes outer membrane localization of the protein
(206). However, mutation of individual amino acids in the
terminal three residues does not seem to affect its localization
significantly.
By analogy to the mechanism of porin biogenesis (480), the
current model proposes that the autotransporter proprotein
spontaneously inserts into the outer membrane in a biophysi-
cally favoured -barrel conformation as it interacts with the
local nonpolar environment of the membrane (Fig. 3) (203).
The first and last -strands spontaneously form hydrogen
bonds in an antiparallel fashion to close the ring conformation,
permitting the establishment of a molecular pore. The alter-
nating hydrophobic side chains of amino acids are embedded
within the hydrophobic lipid bilayer, while the hydrophilic side
chains project into an aqueous environment in the center of
the barrel (507). However, investigations with other outer
membrane proteins, like PhoE and OmpA, suggest that lipo-
polysaccharide (LPS) and the periplasmic chaperone Skp are
required for efficient assembly into the outer membrane (95,
148). Recently, Bulieris et al. (50) proposed the first assisted-
folding pathway of an integral membrane protein by using the
example of OmpA. In this model, once OmpA is translocated
into the periplasm, it binds to three molecules of Skp, which
maintains OmpA in an unfolded state. This OmpA-Skp com-
plex interacts with two to seven LPS molecules to form a
folding-competent intermediate that facilitates insertion and
folding of OmpA into the outer membrane lipid bilayer. It was
suggested that the cochaperone function of Skp and LPS could
be involved in the folding of a large number of outer mem-
brane proteins (50). However, it also appeared that deletion of
the skp gene does not entirely eliminate the presence of outer
membrane proteins in the outer membrane, indicating this
Skp-LPS assisted-folding pathway was certainly not the only
mechanism by which outer membrane proteins insert and fold
into the outer membrane.
Recently, the involvement the surface antigen Omp85 chal-
lenged the idea of a spontaneous assembly of outer membrane
proteins into the outer membrane (517). Omp85 is a highly
conserved protein since homologues are present in all the
complete genome sequences of gram-negative bacteria. Inter-
estingly, the gene is located in close proximity to the skp gene
and to the lpxA and lpxB genes involved in LPS biogenesis. This
protein is essential for cell viability and for outer membrane
protein assembly in mitochondria and bacteria and demon-
strates sequence similarity to Toc75 of the chloroplast protein
import machinery, suggesting a common evolutionary origin
for all systems (155, 518). It has been shown that, following
Omp85 depletion, unassembled forms of various outer mem-
brane proteins, including autotransporters, accumulated. Thus,
Omp85 could possess a general function in the assembly of
outer membrane proteins, although the molecular mechanisms
underlying this function remain to be elucidated. However,
Genevrois et al. challenged this view by demonstrating that
Omp85 was in fact involved in lipid export from the inner to
the outer membrane (154). In this study, the localization of
some outer membrane proteins was not impaired upon Omp85
depletion but degradation products were observed. Interest-
ingly, the isolation of an omp85 knockout mutant in an LPS-
deficient mutant, which would have definitively demonstrated
that Omp85 was involved only in the LPS transport, was im-
possible, suggesting additional function(s) for Omp85. Thus, a
concerted mechanism where Omp85 permits the phospho-
lipid and LPS transport and assembly of the outer mem-
brane as well as the assembly of outer membrane proteins
cannot be completely ruled out and necessitates further
investigations (518).
Translocation of the passenger domain. Originally, it was
proposed that the secretion of the unfolded passenger domain
occurs through the hydrophilic channel formed by the mono-
meric -barrel and that a globular conformation was not com-
patible with this mode of translocation (252–254). In support
of this hypothesis, a recent study has demonstrated the exis-
tence of an ion channel in the -domain of BrkA with an
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average conductance of 3.0 nS in 1 M KCl (449). However,
recent investigations have challenged this long-held hypothe-
sis. Several investigations suggested that the presence or ab-
sence of DsbA, the major periplasmic disulfide bond-forming
catalyst in E. coli, did not make any difference to the stability
and targeting of the passenger domain to the outer membrane
(46, 499, 510). These investigations questioned whether a
structured polypeptide could be translocated through the some-
what narrow hydrophilic channel of a -barrel (355). Indeed,
an alternative model of secretion was proposed after in vitro
investigations of the secretion of gonococcal IgA1 protease
using the -domain embedded in multilamellar liposomes.
This model suggests that the passenger domain is instead se-
creted through an oligomeric ring-shaped structure consisting
of a minimum of six -barrels and forming a central hydro-
philic 2-nm-diameter pore (512). Nevertheless, these re-
searchers also suggested that the oligomeric ring could consist
of as many as 10 monomers and that the exact structure of the
oligomeric ring remained speculative. Such a structure would
be analogous to the outer membrane complexes found in other
secretion systems, e.g., secretin or fimbrial ushers (459, 487,
540). This study has allowed the proposal of an alternative
mechanism for autotransporter secretion through a 2-nm pore
depicted as large enough to tolerate the passage of certain
protein domains in a folded state (Fig. 5) (512). The use of
different immunoglobulin domains, with distinct and defined
folding properties, fused to the IgA1 protease -domain tends
to demonstrate that type Va secretion is compatible with fold-
ed passenger domains containing disulfide bonds following the
action of periplasmic or intramolecular chaperones prior to the
outer membrane translocation (511). However, based on the
available evidence from a variety of different systems, which
each offer only a partial view of the translocation process,
several other hypotheses have been proffered for the outer
FIG. 5. Alternative mechanisms of autotransporter protein secretion. (A) Several different hypotheses have been proffered for the mechanism
of autotransporter protein biogenesis. From left to right are depicted the traditional view of secretion originally proposed by Pohlner et al. (401),
in which the passenger domain passes through the pore of the -barrel to the outside; a recently proposed structure where the passenger domain
extends directly from the -barrel into the extracellular milieu; the secretion pathway proposed by Veiga et al. (512), in which a central channel
is formed through which the passenger domains are secreted to the outside, and the pathway proposed by Hoiczyk et al. (210) for the type Vc
autotransporter family, in which several molecules contribute -strands to make a large -barrel pore through which the proteins are secreted
to the external side of the outer membrane. (B) Crystal structure of the AspA/NalP translocating unit to 2.6 A˚. A side view and a stereo-top
view are depicted. The protein forms a 12-strand -barrel structure characterized by short periplasmic turns and longer external loops. The barrel
interior is highly hydrophilic due to the presence of charged amino acids. Within the barrel is embedded an -helical region, which is attached to
the first transmembrane -strand such that the extreme N terminus of the protein, and to which it is presumed a native passenger domain would
be attached, is located on the extracellular surface. Adapted from reference 366 and the Protein Data Bank (30).
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membrane translocation step. These include scenarios where
the export of the passenger domain occurs through a common
channel shared by the different subunits assembled into a sin-
gle complex and also where the passenger domain is not se-
creted through any pore but, rather, extends directly from the
translocating unit into the extracellular milieu, in a manner
analogous to the YadA-like proteins (Fig. 5) (422, 474).
However, recent evidence has shed light on the translocation
process. On the basis of the sequence alignments published by
Yen et al. (540) the AspA/NalP (or NalP) autotransporter
translocator domain was estimated to consist of a 32-kDa 308-
amino-acid protein. An in vitro refolded version of this domain
demonstrated the same heat modifiability observed with the
native form of the protein (366). Pore activity was measured in
planar lipid bilayers, and two pore sizes were determined, 0.15
and 1.3 nS. The same protein was crystallized, and the struc-
ture was determined to a 2.6-A˚ resolution. As predicted from
the data discussed above, the overall structure of AspA/NalP
was characterized by a -barrel and possessed a pore of 10 by
12.5 A˚ (366). Unlike the 14-strand structure predicted from
bioinformatic analyses, the -barrel consisted of only 12 anti-
parallel -strands. The interior of the barrel was shown to be
highly hydrophilic, with charged amino acids forming patches
axially along the barrel wall in a manner reminiscent of the
protein-translocating outer membrane pore formed by TolC
(see “Type I protein secretion” above). The N-terminally lo-
cated -strand is connected to an -helical stretch of residues
which is located within the pore. The -helix interacts with the
interior of the barrel through salt bridges, hydrogen bonding,
and van der Waals’ forces (366). It is presumed that displace-
ment of the -helix from the pore, which may occur due to the
detergent or salts used in the planar lipid bilayer experiments,
would account for the 1.3-nS activity; the 0.15-nS activity would
occur when the helical region is embedded in the pore (366).
While these data strongly support the original model suggested
by Pohlner et al. (401), it remains possible that the refolded
protein does not adopt its native conformation. Alternatively,
the passenger domain is secreted via a central pore, as pro-
posed by Veiga et al. (512), and subsequently the -helical
region inserts into the -barrel pore after secretion of the
passenger domain. This latter theory has some support from
the different measurements obtained for the pore size in planar
lipid bilayers (366).
Oliver et al. (364, 365) recently discovered an autochaper-
one domain in BrkA. This well-conserved domain, found up-
stream of the translocation unit, is present within the passen-
ger domains of several autotransporters, like AIDA-I, IgA1
protease, Ag43, Hap, and IcsA, but was not detected in some
autotransporters such as TcfA and Hia (365). It was demon-
strated that this domain is important for the folding of the
BrkA passenger domain, probably by triggering or initiating
correct folding of the passenger domain. In BrkA, this domain
could act as an intramolecular building block (305). It was
speculated that this domain might function as a general chap-
erone to scaffold the folding of any protein linked to it. This
autochaperone domain is cleaved from the passenger domain
of PrtS but not from BrkA, suggesting that the folding mech-
anism(s) may differ depending on the autotransporter (365).
Assuming that the model described by Pohlner et al. (401) is
correct, the passenger domain forms a hairpin structure and
appears to remain unfolded, or partially folded, as it travels
through the channel. Indeed, the structure demonstrated for
the -barrel of AspA/NalP revealed a pore sufficiently wide
to accommodate two extended polypeptide chains passing
through the pore simultaneously (366). Then, as the passenger
domain emerges from the -domain channel, folding is trig-
gered beginning vectorially from a C-terminal direction on the
bacterial cell surface. Evidence that passenger folding can oc-
cur on the bacterial surface has been provided by studies of
PrtS autotransporter (362). Interestingly, the passenger do-
mains of the autotransporters demonstrate a high degree of
-helix structure, as predicted from the BetaWrap program
(44), suggesting a structure analogous to pertactin (123) (see
“Cluster 6: Bordetella autotransporters” below); thus, trans-
location of the passenger domains may actually be assisted
by C-terminal winding of the -helix. However, it was shown
recently that while autotransporters lacking the autochaper-
one domain could be translocated and displayed on the cell
surface, they did not fold into their native conformation (365).
Unfortunately, the influence of the autochaperone domain
deletion on the efficiency and kinetics of the passenger domain
secretion is unknown.
Processing of autotransporters at the surface. Once at the
bacterial surface, several alternative processing steps have
been demonstrated for autotransporters. First, the passenger
domain may be processed and released into the extracellular
milieu, e.g., Pet and EspP (49, 124). In contrast, for some
autotransporters like Ag43 (373), AIDA-I (24) and the pertac-
tins (279, 287), once the passenger domain is cleaved, it re-
mains in contact with the bacterial surface via a noncovalent
interaction with the -domain. However, the passenger do-
main is not necessarily cleaved but may also remain intact as a
large protein with a membrane-bound C-terminal domain and
an N-terminal domain extending into the external milieu, e.g.,
Hia or Hsr (367, 465). Nevertheless, the cleavage between the
passenger domain and the translocation unit can occur either
well upstream of the linker region or within the predicted
-helical region, like BrkA (364). In this latter case, BrkA
remains steadfastly associated with the bacterial outer mem-
brane, raising the possibility that the linker region could also
act as an anchor for the passenger domain.
Controversy still exists over how cleavage of the passenger
domain from the translocation unit occurs, especially whether
cleavage is a result of a membrane-bound protease or an au-
toproteolytic event. For IgA1, Hap, and, more recently, App, it
has been demonstrated that the cleavage was the result of an
autoprocessing event involving the integral serine protease ac-
tive sites of the autotransporter, present in the passenger do-
main (206, 401, 445). AIDA-I is also thought to be autopro-
cessed, although no serine protease motif has been found
(472). Passenger domains may also be processed at several
sites and possibly by a variety of protease as observed with
Hap, where the primary autocleavage site was mutated but the
protein was still cleaved at alternative sites (206). Some auto-
transporters have been shown to undergo processing even after
deletion of their serine protease motif, suggesting the action of
alternative proteases (22, 409). It has been demonstrated that
in S. flexneri, IcsA (also called VirG) is cleaved by another
membrane protease, IcsP (also called SopA) (117, 451).
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Interestingly, the IcsA autotransporter has the unusual char-
acteristic of being localized to a single pole of the bacillus
(166). The current model suggests that, on translocation into
the outer membrane at one pole, IcsA, which is anchored in
the membrane by its -domain, diffuses laterally within the
outer membrane such that some of it drifts down the sides of
the bacillus towards the septum (463). IcsP, which is localized
in the outer membrane, slowly cleaves IcsA at all sites on the
bacterial surface, but since the insertion of IcsA is occurring
exclusively at one pole, it results in a unipolar distribution of
IcsA (463). This study raises the question of the fate of the
-barrel once cleavage of the passenger domain has occurred.
By analogy to other outer membrane proteins, the -barrel of
autotransporters might be a rather stable structure (444). Re-
sults from cellular localization studies seem to corroborate the
persistence of the -barrel in the outer membrane (60). How-
ever, this question has not yet been satisfactorily addressed.
One might speculate that accumulation of pore-forming struc-
tures in the outer membrane would be lethal for the bacteria
and that some kind of degradation or regulation process must
therefore occur. However, the degradation mechanism(s) of
periplasmic and outer membrane proteins remains elusive and
requires further investigation, although it might involve
periplasmic enzymes such as DegP and DegQ or outer mem-
brane proteases such as OmpT.
Energy of transport. Comprehensive understanding of the
energy requirements used to translocate proteins across the
bacterial outer membrane has lagged behind the wide-ranging
studies investigating inner membrane transport (378). Since
neither ATP nor GTP occurs in the periplasm, hydrolysis of
these molecules cannot be the driving force for the transloca-
tion of the passenger domain through the outer membrane.
Moreover, there is still no evidence of the existence of a proton
motive force (p) across the outer membrane. The presence of
P-loop nucleotide motifs in several members of the autotrans-
porter family has been reported (203). Proteins bearing a P-
loop motif are not always ATP- or GTP-binding proteins, and
even proteins binding ATP or GTP do not always possess this
motif (433, 522). Subsequently, it was suggested that since
autotransporters can be correctly targeted and exported in
nonnative gram-negative bacterial backgrounds, e.g., gonococ-
cal IgA1 protease in E. coli, no additional secretion function
is required and thus the energy source driving translocation
across the outer membrane is derived from the correct folding
of the passenger domain on the bacterial cell surface (254).
From the study by Veiga et al. (510), where a nonnative single-
chain antibody reporter passenger domain was used, it ap-
peared unlikely that the folding of the passenger domain on
the cell surface would provide the energy required for the
translocation through the outer membrane. Unfortunately, this
set of experiments used a nonnative passenger domain lacking
the intramolecular chaperone domain. Thus, a common sort-
ing mechanism assisting the assembly and export of autotrans-
porter proteins and involving the autochaperone domain may
exist. However, as mentioned above, BrkA lacking the au-
tochaperone domain is still secreted, suggesting that other
factors provide the necessary driving force for secretion. In
conclusion, the energy dependence of the autotransporter se-
cretion is still controversial and speculative and further inves-
tigation is required to clarify this issue.
Evolution and distribution of autotransporter proteins.
While the translocation units of autotransporters are highly
homologous, the passenger domains are very diverse. To date,
all characterized passenger protein domains have been impli-
cated in virulence by displaying enzymatic activity (protease,
peptidase, lipase, and esterase); mediating actin-promoted
bacterial motility; acting as adhesins, immunomodulatory pro-
teins, toxins or cytotoxins, or, as more recently discovered,
permitting the maturation of other virulence proteins (82,
201, 203, 540). The autotransporters are present only in the
Bacteria kingdom and are most prevalent in the phylum
Proteobacteria, including the -, -, -, and ε-Proteobacteria
classes (540). Like the TTSS, the only other phylum in which
autotransporters have also been identified is the phylum Chla-
mydiae, genera Chlamydia and Chlamydophila (198, 213). In
most cases, multiple genes encoding autotransporters are
found throughout the genome sequence of the microorganism,
e.g., E. coli (530), Bordetella spp. (382), Yersinia pestis (98),
Helicobacter pylori (313), Pseudomonas aeruginosa (306) and
Neisseria (91). It has been suggested through genome sequence
analysis that the passenger domain is not always covalently
linked to the -domain, since some open reading frames (ORFs)
code either only for a passenger domain or a -domain. How-
ever, these could simply be pseudogenes, since there is no
experimental evidence that these proteins are expressed (540).
It has been proposed that autotransporter proteins could
have evolved by domain shuffling (91, 303). Functionally novel
autotransporters could arise by linking a new active passenger
domain to a generic -barrel domain. Phylogenetic analysis
showed that horizontal transfer between distant organisms of
the portions of the gene encoding the autotransporter -do-
main was a rare evolutionary event; instead, close homologues
appear to arise almost exclusively by speciation and late gene
duplication events within a single organism. Such analyses have
allowed Yen et al. to classify the autotransporters into 10
distinct phylogenetic clusters (540). However, reinvestigation
of the phylogenetic relationship of the autotransporters reveals
that the proteins can be grouped into at least 11 clusters (Fig.
6) (I. R. Henderson, unpublished data). However, it is clear
that the functional passenger domains have spread by horizon-
tal transfer (91, 201). For example, while the -domains of the
IgA1 proteases and the serine protease autotransporters of the
Enterobacteriaceae (SPATE) have different evolutionary lin-
eages (cluster 8 and 5, respectively), the functional passenger
domains are evolutionarily related and belong to the same clan
of serine proteases (Table 1, Fig. 6). These data suggest that
most autotransporters have arisen through fusion events be-
tween passenger domains and -domains.
Two-Partner Secretion Pathway (Type Vb)
In the bacterial two-partner secretion (TPS) pathway, as
with the autotransporter secretion pathway, the passenger do-
main possesses a signal sequence that directs translocation
across the inner membrane (195). After its export into the
periplasm, the passenger domain inserts into an outer mem-
brane pore formed by a -barrel. Once at the surface of the
bacterium, the passenger domain may undergo further proteo-
lytic processing to achieve its physiological function (221).
However, in contrast to the autotransporter pathway, where
VOL. 68, 2004 TYPE V SECRETION 705
 o
n
 D
ecem
ber 9, 2018 by guest
http://m
m
br.asm
.org/
D
ow
nloaded from
 
the protein is produced as a single polypeptide, the passenger
domain (also called the exoprotein) and the pore-forming
-domain (also called the transporter domain) are translated
as two separate proteins, respectively referred to as TpsA and
TpsB family members (Fig. 3) (221). Compared to the auto-
transporter, the -barrel topology seems different, as indicated
by prediction of 19 amphipathic -strands in TpsB instead of
14 for the autotransporter -domain (176, 303, 540) and dif-
ferent conductance values in artificial bilayers (220, 259). Fur-
thermore, TpsB proteins possess an additional level of com-
plexity, as suggested by their involvement in passenger domain
maturation into an active form (107, 221, 275, 439, 467). The
genes for cognate exoprotein and transporter protein are gen-
erally organized in an operon (221). The TPS pathway implies
specific recognition events between the passenger domain and
the transporter domain. In TpsA, a conserved N-proximal do-
main, called the TPS domain, interacts specifically with TpsB
to initiate the outer membrane translocation (172, 219, 441,
498). Like the autotransporter pathway, the TPS pathway ap-
pears to be dedicated to the secretion of very large proteins,
i.e., 	100 kDa (221). It has been suggested that the exoprotein
transits to the periplasm in an unfolded conformation and
folds progressively at the cell surface as it is translocated
through the transporter domain (175). Thus, the translocation
across both membranes seems coupled and the free energy of
folding might be the driving force for the outer membrane
translocation. Concomitantly with secretion, several passenger
domains undergo further proteolytic processing (221). Inter-
estingly, it has been demonstrated that the B. pertussis auto-
transporter SphB1 acted as a specific protease responsible for
the bacterial surface maturation of FhaB, the filamentous
haemagglutinin (FHA) secreted by the TPS pathway (82).
Thus, despite certain differences, the TPS pathway shares
fundamental features with the autotransporters, the most im-
portant being the mode of secretion described above. More-
over, examination of the signal sequences of TpsA family
members reveals that several of these proteins possess unusual
signal sequences which are remarkably conserved with the
extended signal sequence of autotransporters (Fig. 4) (195,
221). It can be hypothesized that such exoproteins are trans-
located through the inner membrane by the SRP-dependent
pathway, as has been demonstrated for the Tsh/Hbp autotrans-
porter (455). The third line of evidence supporting a connec-
tion with the autotransporter secretion pathway is derived
from phylogenetic analyses, where it has been suggested that
the shuffling of some passenger domains between the auto-
transporter and TPS pathways had occurred frequently in the
course of evolution (195), even though the translocating units
FIG. 6. Phylogenetic tree of the autotransporter proteins. The CLUSTALX and TREE programs were used for multiple alignments and
construction of a phylogenetic tree for the functionally characterized autotransporter proteins. The tree depicted in this figure is derived from
analyses of the C-terminal translocating domains of the autotransporters. Proteins are clustered according to the pattern proposed by Yen et al.
(540). A single additional cluster (cluster 11) is indicated.
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TABLE 1. Functionally characterized autotransporters
Protein Accessionno.
Bacterial
species Mol wt Significant functional motifs Known function Reference
Cluster 1
Ssp P09489 S. marcescens 112,345 Peptidase S8A subtilisin-like serine protease,
RGD cell attachment sequence
Protease 537
Ssp-h1 BAA33455 S. marcescens 107,598 Peptidase S8A subtilisin-like serine protease,
RGD cell attachment sequence
None 360
Ssp-h2 BAA11383 S. marcescens 107,766 Peptidase S8A subtilisin-like serine protease,
RGD cell attachment sequence
None 360
PspA BAA36466 P. fluorescens 102,684 Peptidase S8A subtilisin-like serine protease,
RGD cell attachment sequence, P-loop
ATP/GTP-binding site motif
None 236
PspB BAA36467 P. fluorescens 106,789 Peptidase S8A subtilisin-like serine protease,
P-loop ATP/GTP-binding site motif
None 236
Ssa1 AAA80490 P. haemolytica 103,585 Peptidase S8A subtilisin-like serine protease None 169
SphB1 CAC44081 B. pertussis 109,801 Peptidase S8A subtilisin-like serine protease Proteolytic processing of
secreted proteins
82
AspA/NalP AAN71715 N. meningitidis 113,640 Peptidase S8A subtilisin-like serine protease,
P-loop ATP/GTP-binding site motif,
prokaryotic membrane lipoprotein lipid
attachment site
Proteolytic processing of
secreted proteins
508
Cluster 2
VacA Q48247 H. pylori 139,761 None Vacuolating cytotoxin 393
Cluster 3 and 4
AIDA-I Q03155 E. coli 132,272 None Adherence 24
IcsA AAA26547 S. flexneri 116,244 None Intracellular motility 283
MisL AAD16954 S. enterica 101,216 None None 35
TibA AAD41751 E. coli 101,112 None Adherence/invasion 292
Ag43 P39180 E. coli 106,842 RGD cell attachment sequence, aspartyl
proteases active site, leucine zipper pat-
tern, P-loop ATP/GTP-binding site motif
Biofilm formation 204
ShdA AAD25110 S. enterica 207,033 Hemglutinin repeat, P-loop ATP/GTP-bind-
ing site motif
Adherence, prolonged fecal
shedding of bacteria
249
AutA CAB89117 N. meningitidis 68,386 RGD cell attachment sequence None 3
Cluster 5
Tsh I54632 E. coli 148,227 Peptidase S6 IgA endopeptidase, P-loop
ATP/GTP-binding site motif
Hemaglobinase- and muci-
nase activity, hema binding
409
SepA CAC05786 S. flexneri 145,938 Peptidase S6 IgA endopeptidase, peptidase
S1 chymotrypsin
Tissue invasion? 22
EspC AAC44731 E. coli 140,861 Peptidase S6 IgA endopeptidase Enterotoxic activity 461
EspP CAA66144 E. coli 141,758 Peptidase S6 IgA endopeptidase, P-loop
ATP/GTP-binding site motif
Cytotoxic activity 49
Pet AAC26634 E. coli 139,769 Peptidase S6 IgA endopeptidase, P-loop
ATP/GTP-binding site motif
Enterotoxic and cytopathic
toxin effects, cleavage of
spectrin
124
Pic AAD23953 E. coli 146,450 Peptidase S6 IgA endopeptidase Mucinase activity 196
SigA AAF67320 S. flexneri 139,676 Peptidase S6 IgA endopeptidase Cytopathic activity 5
Sat AAG30168 E. coli 140,043 Peptidase S6 IgA endopeptidase, P-loop
ATP/GTP-binding site motif
Vacuolating cytotoxin 178
Vat AAO21903 E. coli 148,291 Peptidase S6 IgA endopeptidase, P-loop
ATP/GTP-binding site motif
Vacuolating cytotoxin 384
EpeA AAL18821 E. coli 147,340 Peptidase S6 IgA endopeptidase, P-loop
ATP/GTP-binding site motif
Mucinolytic activity 284
EatA AAO17297 E. coli 147,696 Peptidase S6 IgA endopeptidase, peptidase
S1 chymotrypsin clan,
None 385
EspI CAC39286 E. coli 146,131 Peptidase S6 IgA endopeptidase, P-loop
ATP/GTP-binding site motif
Degradation of plasma
proteins
440
EaaA AAF63237 E. coli 141,678 Peptidase S6 IgA endopeptidase None 431
EaaC AAF63038 E. coli 141,673 Peptidase S6 IgA endopeptidase None 431
Cluster 6
Pertactin P14283 B. pertussis 93,453 RGD cell attachment sequence Adherence 61
BrkA AAA51646 B. pertussis 103,377 RGD cell attachment sequence Serum resistance 132
Tef AAQ82668 B. pertussis 65,865 RGD cell attachment sequence Tracheal colonization 141
Vag8 AAC31247 B. pertussis 94,910 RGD cell attachment sequence None 140
Cluster 7
PmpD O84818 C. trachomatis 160,748 None Adherence 464
Pmp20 Q9Z812 C. pneumoniae 179,595 Peptidase S1 chymotrypsin Adherence 234
Pmp21 Q9Z6U5 C. pneumoniae 170,866 None Adherence 234
Continued on following page
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have apparently arisen independently (540). This is supported
by the fact that the homologous passenger domains of the TPS
and autotransporter pathways perform similar functions (195,
218). However, it is still difficult to discriminate between a
divergent evolution from a common ancestor or a convergent
evolution toward a similar solution for secretion of large pro-
teins across the outer membrane (195, 202, 218). Interestingly,
the efficient extracellular release of mature FHA depends on
the presence of a C-terminal domain of FhaB, which is pro-
teolytically removed in the course of secretion and acts as an
intramolecular chaperone to assist secretion by preventing pre-
mature folding (414). These data highlight further similarity
between the proteins secreted through the TPS pathway and
the recent finding of an autochaperone domain in some auto-
transporters (365). From the similarities between the TPS and
autotransporter pathways described above and the established
fact that secretion in gram-negative bacteria is constrained by
outer membrane translocation and not by the inner membrane
pathways, Henderson et al. (195, 202) proposed that the TPS
pathway should be grouped under the type V secretion um-
brella as a distinct subgroup.
Type Vc
Recently, the members of the Oca (for “Oligomeric Coiled-
coil Adhesins”) family have been described as a subfamily of
surface-attached oligomeric autotransporters, with the Y. pestis
YadA as the prototypical example (356, 422). YadA possesses
six different domains: (i) an N-terminal signal sequence, (ii)
head-D, (iii) neck-D, (iv) stalk-D, (v) linking-R, and (vi) a
C-terminal region consisting of only four -strands (210). Like
the autotransporters, deletion of the C-terminal domain abol-
ished outer membrane insertion of YadA (479) while the de-
letion of the linker region resulted in degradation of the whole
protein (422). This region is proposed to form a -barrel pore
consisting of 12 -strands after trimerization and confers an
overall lollipop-like structure on the proteins displayed on the
cell surface (210). TolC possesses an analogous -barrel struc-
ture, although it also possesses -helical regions which extend
into the periplasmic space (Fig. 2) (263). Recent structural
investigations have demonstrated that the H. influenzae Hia
adhesin is a trimeric protein secreted in a manner analogous to
YadA rather than the true autotransporters, as previously de-
scribed (465, 474, 541). This type of trimeric conformation and
mode of secretion has been proposed as an alternative model
for autotransporter secretion system (see above) and has been
designated the type Vc or AT-2 pathway (Fig. 3).
The passenger domains of the AT-2, two-partner, and auto-
transporter protein secretion systems correspond to the func-
tional secreted effector molecule. To date, all of the function-
ally characterized passenger domains have been implicated in
bacterial virulence (74, 82, 201, 203, 221, 422). While over
1,000 autotransporters can be identified in GenBank, relatively
few have been characterized at the functional level. Critical
TABLE 1—Continued
Protein Accessionno.
Bacterial
species Mol wt Significant functional motifs Known function Reference
Cluster 8
IgA1 protease NP_283693 N. meningitidis 196,351 Peptidase S6 IgA endopeptidase Degradation of IgA1 LAMP-1,
and synaptobrevin
300
App CAC14670 N. meningitidis 159,072 Peptidase S6 IgA endopeptidase, peptidase
S1 chymotrypsin, RGD cell attachment
sequence
Adherence 182
IgA1 protease P45386 H. influenzae 202,957 Peptidase S6 IgA endopeptidase, P-loop
ATP/GTP-binding site motif
Degradation of IgA1 406
Hap P45387 H. influenzae 155,440 Peptidase S6 IgA endopeptidase, peptidase
S1 chymotrypsin
Adherence, microcolony
formation
466
Cluster 9
rOmpA P15921 R. rickettsii 224,333 None Adherence 10
rOmpB Q53047 R. rickettsii 168,184 None Adherence 163
Cluster 10
ApeE AAC38796 S. enterica 69,862 Lipolytic GDSL active-site enzyme Hydrolysis of naphthyl esters 58
EstA AAB61674 P. aeruginosa 69,609 Lipolytic GDSL active-site enzyme Lipolytic activity 533
Lip-1 P40601 X. luminescens 70,717 Lipolytic GDSL active-site enzyme, leucine
zipper pattern
Hydrolysis of naphthyl acetate,
Tween 80, and p-nitrophenyl-
palmitate
523
McaP AAP97134 M. catarrhalis 71,484 Lipolytic GDSL active-site enzyme Hydrolysis of phophatidylcho-
line and lysophosphatidyl-
choline, and adherence
489
Cluster 11
BabA AAC38081 H. pylori 80,345 None Adherence to Lewisb blood
group antigen
215
SabA AAD06240 H. pylori 72,169 None Adherence to sialic Lewis an-
tigen
308
AlpA CAB05386 H. pylori 56,124 Leucine zipper pattern Adherence to Lewis x antigen 358
Unassigned
Aae AAP21063 A. actinomyce-
temcomitans
100,609 None Adherence 423
NanB AAG35309 P. haemolytica 119,791 RGD cell attachment sequence sialidase Sialidase activity 329
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aspects of the characterized autotransporters are listed in Ta-
ble 1, and the functions of each are discussed in detail below.
We have framed the discussion around the phylogenetic clus-
ters identified in Fig. 6. For expediency, proteins of similar
functional activity are discussed under the same heading.
CLUSTER 1: SUBTILASE FAMILY OF
AUTOTRANSPORTERS
The subtilase group of autotransporters is part of an exten-
sive family sharing a catalytic site characterized by a charge
relay system resembling the trypsin family but having appar-
ently evolved convergently. The sequence surrounding the
residues involved in the catalytic triad (Asp, Ser, and His
residues) is different from the analogous residues in the tryp-
sin-like serine proteases (268). Since this family is best char-
acterized for Bacillus subtilus, its members are referred to as
the subtilases and are characterized by the conserved domain
pfam00082 (314).
Ssp
Several subtilase autotransporters from different species
have been identified. The first member was found in 1986 by
Yanagida et al. (537) in Serratia marcescens, and its secretion
system was elucidated almost at the same time that Pohlner et
al. (401) proposed it for the IgA1 protease. Sequencing of the
gene encoding this subtilase serine protease (Ssp) revealed
that it contained an open reading frame encoding a 112-kDa
protein. These authors found that the mature protein (41
kDa), which contains the catalytic triad (D49, H85, and S314), is
the middle part of a proenzyme, which starts at A28 and fin-
ishes at D408. Interestingly, the secretion of the protease into
the extracellular medium through the outer membrane of the
E. coli host cell occurs in parallel with their growth (537).
Additional data from the same group have shown that (i) the
112-kDa precursor is detected in an insoluble form in the
periplasmic space of E. coli cells after isopropyl--D-thiogalac-
topyranoside (IPTG) induction of the expression of the gene
under the control of the tac promoter, (ii) the mutated gene
product lacking all the C-terminal domain was localized in the
periplasmic space only, (iii) the mutant protein with no pro-
tease activity because of the change of the catalytic residue S341
to T341 was still secreted into the medium but with abnormal
processing, (iv) the signal sequence was essential for the se-
cretion of the mature protease of 66 kDa into the medium, and
(v) cleavage of the mature extracellular Ssp from the -domain
occurred via an autocatalytic event and at several sites in the
junction region between the passenger and -domains. Fur-
thermore, the N-terminal portion of the -domain (S646 to
G716), called the junction region of the Ssp precursor, was
found to play a role in folding the mature protease domain in
a manner analogous to the BrkA intramolecular chaperone
domain described above. Finally, the extracellular transport of
a foreign periplasmic protein, pseudoazurin of Alcaligenes fae-
calis, using the -domain of Ssp was detected in E. coli (328,
361, 362, 452, 453).
Southern hybridization analysis with a DNA fragment en-
coding the -domain of Ssp as a probe showed a wide distri-
bution of nucleotide sequences encoding Ssp exporter-like pro-
teins among Serratia species. Moreover, S. marcescens IFO
3046, from which the ssp gene had been cloned, was found to
contain two ssp homologues, called ssp-h1 and ssp-h2 (360).
ssp-h1 and ssp-h2 showed 55% identity in the amino acid se-
quence to Ssp. Furthermore, both genes are located in tandem
on the genome, and the amino acid sequences of their products
showed 81% identity to each other, suggesting that one of
them was generated by gene duplication during evolution
(360). E. coli JM105 containing the ssp-h1 gene produced a
53-kDa protein corresponding to the N-terminal portion and a
49-kDa protein corresponding to the C-terminal portion, both
of which were rigidly integrated in the outer membrane. Fur-
thermore, both ssp-h1 and ssp-h2  domains, by using chimeric
proteins, showed the ability to translocate the mature SSP part
across the outer membrane into the medium, and the N-ter-
minal part of the homologue was not translocated into the
outer membrane without its C-terminal part.
PspA and PspB
Kawai et al. (236) found two ORFs (genes pspA and pspB)
encoding proteins of 985 and 1036 amino acids, respectively,
which were localized between the aprDEFPF33 and lipAPF33
genes of Pseudomonas fluorescens 33. PspA is 53% identical to
PspB, and both are homologous to the S. marcescens subtilases.
Three motifs for the active sites (D, H, S) of subtilases are also
found in the PspA and PspB sequences. Interestingly, E. coli
harboring pspA secretes a protein of 51 kDa into the superna-
tants from cultured media at 23°C, but when cultured at 37°C
they produced only an insoluble protein of 51 kDa. In contrast,
in Pseudomonas fluorescens, PspA is only detected in the ly-
sates of cells cultured at 37°C but not at 23°C (236).
Ssa1
Despite the extensive investigation of the secretion of these
subtilase family autotransporters, which started with Ssp in
1986, there is little information about the role of these proteins
in vivo. Interestingly, these genes showed end-to-end similarity
to the 100-kDa serotype-specific antigen 1 (Ssa1) of Mannhei-
mia (Pasteurella) haemolytica (169, 360). Ssa1 appears to play a
role in the pathogenicity of M. haemolytica. M. haemolytica
strains have been grouped into 15 serotypes on the basis of
standardized typing antisera raised in rabbits. In contrast to
S. marcescens and P. fluorescens, M. haemolytica serotype 1 has
been established as the primary agent responsible for acute
lobar fibrinonecrotizing pleuropneumonia in cattle. Serotype 1
is rarely found in healthy cattle, but serotype 2 is cultured
frequently from the upper respiratory tracts of healthy animals
(169, 297). Interestingly, both serotypes possess the gene en-
coding serotype-specific antigen Ssa1 but M. haemolytica sero-
type 2 strains do not express serologically detectable levels
of the Ssa1 protein. In addition, cattle showing resistance to
pneumonic pasteurellosis possess antibodies to Ssa1 which ap-
pear to be protective (531).
SphB1
SphB1 is a newly described Bvg-regulated Bordetella auto-
transporter (82). It has 24% sequence identity to Ssp and is
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necessary for the surface maturation of a Bvg-regulated adhe-
sin called filamentous hemagglutinin (see Two-Partner Secre-
tion Pathway above). A serine protease (subtilase) motif is
evident, and mutation of Ser412 to Ala inhibited the processing
of FHA. In fact, the Ser-to-Ala mutation also prevented pro-
cessing of SphB1 upstream of its -domain, suggesting that
SphB1 is autocatalytic. Since the -domains of BrkA, pertac-
tin, and Tcf were found in the Ser-to-Ala mutant, SphB1 is not
responsible for their cleavage and is thought to have a function
unique to FHA maturation (82). Like many other autotrans-
porters, the passenger domain of SphB1 is attached to the
bacterial surface, although a small amount was found shed in
the supernatant. Anchoring of SphB1 to the bacterial surface is
mediated by lipid modification of the N terminus of SphB1.
Globomycin treatment or mutation of the cysteine residue in
its conserved lipid modification site (Leu-Ala-Ala-Cys) abro-
gated the surface localization of SphB1, providing further ev-
idence that SphB1 is indeed a lipoprotein (83). The ProDom
domain PD011682 (76), which was associated with an in-
tramolecular chaperone-like function in Ssp, is also present
in SphB1; it is found in the area described as region IV, which
bridges the subtilisin domain and the -domain.
AspA/NalP
In addition to IgA1 protease, N. meningitidis appears to
possess several autotransporter proteins. Recently, in a search
for immunogenic virulence factors of N. meningitidis by us-
ing several molecular, immunological, and bioinformatic ap-
proaches, the Ala’Aldeen group has identified at least five
autotransporter proteins including AutA, AutB, App, MspA,
and AspA/NalP (3, 182, 495; D. A. Ala’Aldeen, unpublished
data). AspA/NalP (for “Autotransported Serine Protease A”
also called neisserial autotransported lipoprotein [NalP]) is a
highly conserved, autotransported, 112-kDa subtilase, which
was identified from the meningococcal genome sequence data
by using bioinformatics techniques (495). This protein has sig-
nificant N-terminal homology to the secreted subtilases from
several organisms and contains a serine protease catalytic
triad. The amino acid sequence of AspA/NalP is well con-
served in meningococci. In N. gonorrhoeae, AspA/NalP ap-
pears to be a pseudogene. It also exhibits autocleavage activity,
leading to the release of a 68-kDa fragment into the external
milieu (495). The signal sequence contains a signal peptidase II
cleavage motif, suggesting that AspA/NalP may be a lipopro-
tein. A well-characterized homologue of AspA/NalP, SphB1 in
B. pertussis, is an important virulence determinant, which is
responsible for the timely cleavage of the FHA precursor,
leading to the secretion of mature FHA (82; see above). In-
terestingly, meningococci appear to possess the two genes
(fhaB and fhaC) corresponding to B. pertussis fhaB and fhaC,
which are secreted via the two-partner secretion pathway de-
scribed above. AspA/NalP also shows homology to the sero-
type 1 antigen, Ssa1, from M. haemolytica A1, which causes a
fibrinonecrotizing pleuropneumonia in cattle (297). The gene
encoding AspA/NalP was cloned and expressed from menin-
gococcal strains MC58 (B15:P1.16b) and H44/76; in the latter
case, the protein was designated NalP and the crystal structure
of the -domain has been solved (see “-domain” above).
Anti-AspA/NalP antibodies were detected in patients’ conva-
lescent-phase sera, suggesting that AspA/NalP is expressed in
vivo during infection and is immunogenic and cross-reactive.
Rabbit polyclonal monospecific anti-AspA/NalP serum was
used to probe whole-cell proteins from a panel of wild-type
meningococcal strains and two AspA/NalP-mutant strains. Ex-
pression of the ca. 112-kDa precursor polypeptide was de-
tected in 12 of 20 wild-type meningococcal strains examined,
indicating that AspA/NalP expression is phase variable. Immu-
nogold electron microscopy and cellular fractionation studies
showed that the AspA/NalP precursor is transported to the
outer membrane and remains surface exposed. Western blot
experiments confirmed that smaller, ca. 68- or 70-kDa compo-
nents of AspA/NalP (AspA68 and AspA70, respectively) are
then secreted into the meningococcal culture supernatant.
Site-directed mutagenesis of S426 abolished the secretion of
both rAspA68 and rAspA70 in E. coli, confirming that AspA/
NalP is an autocleaved autotransporter protein. Interestingly,
like SphB1 (see Bordetella Autotransporters below), AspA/
NalP alters the secretion of other bacterial proteins, namely,
App, MspA, and IgA1 protease (508).
CLUSTERS 2 AND 11: HELICOBACTER PYLORI
AUTOTRANSPORTERS
H. pylori is a gram-negative bacterium that colonizes the
gastric mucosa of humans. Colonization with H. pylori is an
important risk factor for the development of gastric and duo-
denal (peptic) ulcers, gastric adenocarcinoma, and gastric lym-
phoma (341). As in other complicated host-pathogen interac-
tions, bacterial and host-related factors are important in the
disease process. However, the exact mechanism by which H.
pylori damages the human epithelial cell is not known. The
bacterium expresses numerous virulence factors including the
autotransporters VacA, BabA, SabA, and AlpA (201, 335,
408). Numerous other putative autotransporter proteins have
been identified in the genome of H. pylori; however, they have
not been well characterized (57).
VacA, the Vacuolating Cytotoxin
All H. pylori strains contain a copy of the vacA gene, which
varies in length (3.9 kb 
 35 bp) among strains. Its transcrip-
tional start point is located 119 bp upstream of the ATG start
codon (144). VacA possesses features typical of an autotrans-
porter protein, including a 33-amino-acid signal sequence, a ca.
90-kDa N-terminal passenger domain, and a 33-kDa C-termi-
nal transporting unit (393). The 33-kDa C-terminal domain of
VacA possesses the hallmarks of a -barrel structure, and
immunoblot experiments have confirmed that it is retained in
the outer membrane of H. pylori (484).
Molecular and structural features. Like many other auto-
transporters, the 90-kDa passenger domain is cleaved and se-
creted to the extracellular environment. Under nondenaturing
conditions, the VacA passenger domains aggregate into large
oligomeric complexes (84). Examination of the ultrastructure
of rapidly frozen purified VacA, using deep-etch electron mi-
croscopy, demonstrated that the toxin assembles into large
ring-form (flower-shaped) or flat-form complexes. The flower-
shaped forms are about 30 nm in diameter and appear to
consist of a central ring surrounded by six or seven “petals”
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(304). The flat-form complexes also consist of six or seven
petals radiating from the center of the complex with a distinc-
tive clockwise chirality but with no central ring. Atomic force
microscopy imaging of purified VacA supports the deep-etch
electron microscopy data and suggests that VacA is arranged
in hexagonal central rings attached by connectors to peripheral
domains (87). Following exposure to acidic or alkaline pH, the
oligomeric complex dissociates into the 90-kDa monomeric
units. This dissociation is probably important for the biological
functionality of the protein; exposure of the purified oligo-
meric toxin to acidic or alkaline pH (activation) results in
enhanced internalization of the toxin and a marked increase in
its cytotoxic activity (85, 94, 321, 332, 535).
Like the IgA1 proteases the VacA passenger domain is fur-
ther processed after secretion, separating into two subdomains
i.e., p33, a 33-kDa N-terminal subdomain, and p55, the 55-kDa
C-terminal region (351). H. pylori mutant strains, constructed
with in-frame deletions in the p33 subdomain, express trun-
cated VacA proteins which are secreted but which fail to oli-
gomerize and lack detectable cytotoxic activity (415, 514). A
VacA mutant, lacking most of the p33 subdomain, has been
characterized in detail and found to form water-soluble dimers
that have an ultrastructural appearance similar to that of the
peripheral petals of VacA oligomers (415). This suggests that
the peripheral petals of VacA oligomers correspond to the p55
subdomain. The two subdomains can be separated by limited
proteolysis or by slow autodegradation during prolonged stor-
age (85, 304). The cleavage site, which contains multiple
charged amino acids, is thought to form a surface-exposed loop
which is likely to add flexibility to the overall structure, al-
though it does not appear to affect the level of cytotoxic activity
(53).
Vacuolating activity. The most striking feature of VacA is its
ability to induce the formation of prominent intracellular vacu-
oles in cultured cells. The current model suggests that oligo-
meric VacA binds to the plasma membrane on the apical
portion of the epithelial cell. The oligomerized p55 subdo-
mains act as the host cell receptor-binding domain (152). At
least three different proteins have been implicated as the re-
ceptor for the p55 subdomain (149, 374, 446); however, several
groups have demonstrated that VacA binds to lipid rafts and
glycosylphospahatidylinositol (GPI)-anchored proteins, sug-
gesting that VacA interacts with cholesterol-rich microdo-
mains (270, 416, 442).
After initial binding, VacA inserts into the plasma mem-
brane, forming anion-selective channels (477). Eventually, the
toxin is internalized by endocytosis and forms a pore located in
a membrane-delimited vacuole. These vacuoles contain both
late endosomal and lysosomal markers and appear to result
from successive fusion between internal membranes with the
limiting membrane of late endosomal compartments (333).
The influx of anions alters the permeability of the vacuoles,
eventually leading to water flux and vesicle swelling, thus form-
ing the large vacuoles characteristic of VacA activity.
The p33 subdomain is considered the enzymatically active
part of VacA, which becomes exposed to the host cell cytosol
and influences the regulation of endosome-endosome fusion.
Experiments with epithelial cell lines transfected with plasmid
constructs encoding various lengths of the functional domain
of VacA showed that the p33 subdomain is fully active when
associated with the intersubdomain loop and a small fragment
of p55. Loss of the remainder of the p55 C-terminal subdomain
has no deleterious effect on the vacuolating activity of the
molecule (92, 539). Furthermore, the loss of the first 6 or 10
N-terminal amino acids of the p33 subdomain led to partial or
total loss of vacuolating activity, respectively (92, 539). The loss
of amino acids 6 to 27 rendered the VacA molecule inactive
but structurally unchanged (525). Further, point mutations at
proline 9 or glycine 14, using alanine scanning mutagenesis,
abolished VacA activity (538).
Host cell vacuolation may slowly but eventually lead to the
death of primary human gastric epithelial cells (458). It is not
known if this process reflects events occurring in vivo, although
animal work clearly points to a loss of epithelial cells (285).
Various studies have shown an association between vacuolat-
ing activity of the organism and peptic ulcer disease. H. pylori
strains that express vacuolating cytotoxic activity in vitro are
more commonly (but not absolutely) associated with disease
than are noncytotoxic strains. In addition to direct damage to
gastric epithelial cells, VacA is thought to contribute to the
capacity of H. pylori to colonize and persist in the human
gastric mucosa.
Other functions. While the hallmark of VacA activity is its
ability to produce vacuolization in cultured cells, it demon-
strates properties of a multifunctional protein. In addition to
causing the formation of intracellular vacuoles, VacA inter-
feres with the process of antigen presentation (334), increases
the permeability of polarized epithelial monolayers (380), acts
as a urea permease that promotes urea diffusion across epi-
thelia (491), produces enterotoxic effects in Ussing chambers
(174), acts as a hexameric chloride channel in mammalian
membranes (217), interacts with a cellular protein associated
with intermediate filaments (93), and induces apoptosis (151,
388). Indeed, examination of the recent evidence suggests that
induction of apoptosis may be the primary role of VacA (38),
although the contribution of such activity to the life-style of
H. pylori remains enigmatic.
Epidemiology of H. pylori infection. VacA is highly con-
served in terms of its distribution among H. pylori population;
however, despite the importance of VacA for virulence and its
structure-function relationship, there are extensive variations
in its DNA and amino acid sequences. This sequence variation
is most marked in a ca. 800-bp central region, termed the
“mid-region,” which covers a large portion of the p55 subdo-
main coding area, and the “signal region,” which encompasses
the distal region of the signal sequence and a small part of the
p33 subdomain. The remainder of the p33 subdomain is rela-
tively well conserved between alleles (14, 15), although there is
evidence of recombination (170, 471).
Phylogenetic analysis of the variable mid-region has enabled
the classification of vacA into two allelic families, termed type
m1 and type m2 (14, 15). H. pylori strains with either allele are
widespread in most human populations examined, although
type m2 alleles are rare among the Japanese (16, 216, 536).
Analysis of H. pylori isolates from unrelated individuals indi-
cates that recombination within the alleles is common (471),
but the main families have remained relatively intact (15, 379,
524). This suggests that various in vivo selective forces favor
the preservation of these structures.
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Two main signal region allelic families are recognized,
termed s1 (sla, slb, and slc) and s2. Cleavage of the signal
sequence in type s1 and type s2 VacA occurs at different
locations (16). After cleavage, the secreted type s2 VacA is left
with a hydrophilic amino terminus, and several studies have
suggested that type s2 VacA proteins are relatively noncyto-
toxic in vitro compared to type s1 VacA proteins (280). Indeed,
McClain et al. (320) reported that a 12-amino-acid hydrophilic
N-terminal segment, which is present in type s2 but absent
from type s1 VacA proteins, diminishes the capacity of VacA
to form membrane channels and induce cytotoxic effects.
Interestingly, VacA molecules encoded by type s1/m1 vacA
alleles are associated with a high level of vacuolating cytotoxin
activity (14), and are active on a wide variety of epithelial cell
lines. In contrast, other forms of VacA (e.g., type s1/m2) are
associated with a lower or absent vacuolating activity. While
these remain active against primary gastric epithelial cells and
RK-13 cells, they are minimally active on HeLa cells (376).
This difference in cell type specificity may be due to differences
in the binding capacity of the p55 (binding) subdomains (376).
These data are supported by examination of chimeric s2/m1
VacA constructs, which lacked activity and inhibited the vac-
uolating activity of wild-type s1/m1 VacA, presumably through
formation of hetero-oligomeric complexes (281, 320).
The classification of vacA alleles according to families, par-
ticularly according to type s1 or type s2, seems to correlate with
the risk for clinical disease. Numerous studies have concluded
that peptic ulceration occurs more commonly among patients
infected with H. pylori strains containing a type s1 vacA allele,
although this association is less apparent in many Asian coun-
tries than in Europe and the Americas (375). To account for
the association of certain vacA genotypes with peptic ulcer
disease in Western countries, several possible explanations
have been suggested. First, the type s1 allele is associated more
frequently with the presence of other virulence factors that
play a role in the pathogenesis of peptic ulcer disease than is
the type s2 allele, e.g., the cag PAI and the BabA adhesin (14,
157, 359, 389, 425). This suggests that multiple bacterial factors
contribute to ulcerogenesis. Second, H. pylori strains with the
type s1 allele produce higher levels of VacA than do strains
with type s2 allele (144). Finally, the type s1 VacA proteins are
more cytotoxic than the type s2 proteins and therefore may
cause greater gastric epithelial damage, thereby contributing to
the pathogenesis of peptic ulceration (14, 144, 159, 280).
It is interesting that most studies have not shown an associ-
ation between the mid-region alleles and disease, although two
studies have shown an association of type m1 strains with
gastric adenocarcinoma (239, 506). The latter disease is highly
prevalent in Japan, where nearly all the prevalent strains are of
this vacA genotype. This homogeneity suggests that vacA ge-
notype and phenotype are not potentially useful markers of
more pathogenic strains within Japan.
BabA, SabA, and AlpA
In addition to VacA, H. pylori expresses a number of other
autotransporter proteins. These can be predicted in silico
based on the deduced molecular features of ORFs. Two H.
pylori autotransporter proteins, BabA and BabB, have recently
been characterized (215). BabA was the first to be fully char-
acterized. This 78-kDa outer membrane protein was success-
fully cross-linked to the human Lewisb (-1,3/4-difucosylated)
blood group antigens expressed on gastric epithelial cells (39,
40, 215). Thus, BabA2 is thought to act as a potent adhesin that
not only mediates attachment of the organism to human gastric
epithelium and protects it from gastric acidity and peristalsis
but also contributes to the specific tropism of H. pylori.
It is interesting that all members of a subset of strains ex-
pressing BabA bound to Lewisb-coated microtiter dishes
whereas organisms which did not express the protein did not
adhere (157). In vitro adherence assays revealed that H. pylori
bound in a lineage-specific manner to gastric surface mucous
cells mediated by fucosylated blood group antigens (128).
Moreover, studies with transgenic mice expressing the human
Lewisb epitope in gastric epithelial cells indicated that Lewisb
functions as a receptor for a H. pylori adhesin and mediates its
attachment to gastric pit and surface mucus cells (129). At-
tachment of H. pylori to gastric epithelial cells in such trans-
genic mice resulted in the development of chronic gastritis and
gastric atrophy (177).
The expression of BabA is probably phase variable, and the
gene contains a repeat motif which undergoes frequent dele-
tion and slip-strand mispairing. This phase variation can be
significant in helping the organism avoid host defence mecha-
nisms.
BabA and BabB are members of a paralogous family of
outer membrane proteins, in which the members have signifi-
cant N- and C-terminal similarity (490), suggesting possibilities
for increased chances of recombination and enhanced capabil-
ity of antigenic variation; babA and babB are almost identical
in their 5 and 3 regions, with most of their sequence diver-
gence being in their passenger domain mid-regions (7, 215).
The sequence polymorphism of babA has been studied in de-
tail, and several allelic types have been recognized. One spe-
cific allelic type, named babA2, appears to be associated with
clinical disease (see below).
Pride et al (407) examined the relationships between babA
and other members of this family of proteins and the diversity
that exists within babA and babB. Eleven family members
within a single H. pylori strain were classified as babA paral-
ogues. These were predicted to encode proteins with substan-
tial N- and C-terminal similarity to each other. In their central
regions, most are less than 54% related to one another. Ex-
amining the babA and babB central regions in 42 H. pylori
strains from different geographic locales, they also identified
five different allele groups of babA (AD1 to AD5) and three
different allele groups of babB (BD1 to BD3). Phylogenetic
analysis revealed that the allelic groupings of babA and babB
are independent of one another and that, for both, geographic
variation is present.
Studies with transgenic mice expressing the Lewisb epitope
have shown that such attachment can alter disease outcome.
Gerhard et al. (157) demonstrated that the babA2 gene is of
high clinical relevance in Western countries and would be a
useful marker to identify patients who are at higher risk for
specific H. pylori-related diseases. They studied the presence of
the babA2 gene encoding the adhesin in clinical isolates from
a German population by using PCR and reverse transcription-
PCR. The presence of babA2 was significantly associated with
duodenal ulcer and adenocarcinoma. The presence of babA2,
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vacAs1, and cagA in the genotype (“triple-positive” strains)
showed a highly significant correlation to the prevalence of
ulcer and adenocarcinoma. In contrast, however, Mizushima et
al. (330) investigated the presence of babA2 and cagA in 179
Japanese clinical isolates by PCR and Southern blot analysis
and looked for correlations with various clinical outcomes. The
results indicate that babA2 status is not of high clinical rele-
vance in Japan and that Japanese strains are different from
those infecting Western populations.
A recent investigation of a babA null mutant found that this
strain bound to the gastric mucosa of an H. pylori-infected
patient with gastritis (308). Analysis of the glycosphingolipids
bound to the surface of the babA mutant revealed that this
strain could bind sialyl-dimeric Lewisx antigen. Utilizing the
same “retagging” method that was used to identify BabA,
Mahdavi et al. (308) identified SabA as the adhesin responsible
for binding the sialic Lewis antigen. This adhesin belongs to
the same paralogous family as BabA. Like BabA, SabA ap-
pears to be phase variable and possesses an apparently non-
functional homologue, SabB. Interestingly, these researchers
demonstrated that H. pylori was able to modulate the expres-
sion of the sialic Lewisx antigen on the surface of the host
epithelial cell, causing an up regulation during persistent in-
fection. Subsequent analyses demonstrated that SabA was also
capable of mediating the binding to sialic Lewisa antigens,
which is particularly noteworthy when one considers that this is
an established tumor antigen and marker of gastric dysplasia
(308).
Recently, two paralogous autotransporter genes, alpA and
alpB, were identified. Using several molecular techniques,
Odenbreit et al. (358) demonstrated that these genes were
organized in an operon and that expression of both genes was
required for a specific adherence of H. pylori to human gastric
tissue sections. Subsequently, these investigators revealed that
the adherence mediated by AlpA and AlpB was independent
of the Lewisx antigen (357). Interestingly, AlpA possesses a
lipoprotein signal sequence; however, acylation of the protein
could be demonstrated only in E. coli and not in the wild-type
H. pylori background (see “Inner membrane transport” above).
CLUSTERS 3 AND 4: AIDA
AUTOTRANSPORTER FAMILY
The largest subfamily of autotransporters is defined by the
AidA conserved domain COG3468 (representing 644 residues
spanning the passenger and -domains) and consists of mem-
bers from a diverse range of animal and plant pathogens in-
cluding E. coli, S. enterica, Y. pestis, N. meningitidis, Pasteurella
multocida, A. tumefaciens, Mesorhizobium loti, and Brucella
melitensis (314). This subfamily, which is composed of more
than 55 proteins, possesses some of the best-characterized
autotransporter proteins including the S. flexneri mediator of
motility IcsA, the major phase-variable E. coli outer membrane
protein antigen 43, and the diffuse adhering E. coli adhesin
AIDA-I, from which this family derives its name. Despite the
fact that this subfamily contains such well-characterized pro-
teins, most members remain uncharacterized. Interestingly,
the passenger domains of these autotransporter proteins dis-
play homology to wide array of proteins secreted via other
protein secretion pathways, e.g., the B. pertussis FHA secreted
via the TPS pathway (see above) (195) and the V. cholerae
RtxA protein secreted by a type 1 pathway (289).
AIDA-I
Classical enteropathogenic E. coli (EPEC) strains were orig-
inally classified by serotype; however, over the past two de-
cades it has become clear that the classical EPEC strains were
composed of several different pathotypes of E. coli as defined
by the pattern of adherence manifested in HeLa cell culture
assays. Today, only strains displaying a localized pattern of
adherence are referred to as EPEC, with diffuse-adhering
E. coli (DAEC) and enteroaggregative E. coli (EAEC) being
recognized as separate distinct pathotypes with differing viru-
lence factors and mechanisms of mediating diarrheal disease
(346).
One of the classical EPEC strains that displayed a diffuse
adhering phenotype was E. coli strain 2787 (O12:H27), which
was isolated from a patient with infantile diarrhea (25). Since
the genes responsible for the localized phenotype were found
on a large plasmid, Benz and Schmidt (25) hypothesized that
the factor responsible for conferring the diffuse-adhering phe-
notype might also be located on an extrachromosomal ele-
ment. By transforming E. coli C600 with recombinant clones
containing fragments of the E. coli strain 2787 plasmids and
examining the transformants for a diffuse-adhering pattern in
the HeLa cell culture assay, these researchers were able to
define the region responsible for the diffuse pattern of adher-
ence as a 6-kb fragment from one of the large virulence plas-
mids (25, 26). This 6-kb fragment was shown to encode two
proteins with predicted molecular masses of 44.8 and 132 kDa,
termed Aah and AIDA-I, respectively. Several lines of evi-
dence supported the theory that the AIDA-I protein was re-
sponsible for the diffuse-adhering phenotype, including the
following: (i) mutant strains had a diffuse-adhering negative
phenotype, (ii) specific antisera to AIDA-I inhibited bacterial
attachment to HeLa cells, and (iii) electron microscopy dem-
onstrated that the protein was surface localized (29).
Subsequent investigations revealed that the 132-kDa protein
was processed posttranslationally in a manner consistent with
secretion via the autotransporter pathway; thus, the AIDA-I
protein was processed into a passenger domain with a pre-
dicted molecular mass of 79.5 kDa and a -domain of 47.5 kDa
(24, 27, 472). Interestingly, the passenger domain possessed
several characteristics reminiscent of the E. coli surface protein
antigen 43 (see below), including the facts that (i) after pro-
cessing it remains associated with the cell surface through a
noncovalent interaction, (ii) it can be released from the cell
surface by heating to 60°C; (iii) it displays an aberrant migra-
tion pattern on sodium dodecyl sulfate-polyacrylamide gel
electrophoresis (SDS-PAGE) under denaturing conditions,
migrating with an observed molecular mass higher than the
predicted molecular mass (100 kDa in the case of AIDA-I);
and (iv) it possesses a highly repetitive structure consisting of
31 conserved repeats composed of 19 to 21 amino acids each
(24). Furthermore, purification of AIDA-I using gel filtration
columns revealed that the purified AIDA-I passenger domain
aggregates together, eluting in the 450- to 600-kDa range and
suggesting a pentameric or hexameric structure (271). In silico
analyses of the AIDA-I protein suggested that the passenger
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domain possessed a significant amount of -strand structure.
Furthermore, empirical data from circular dichroism spectra
indicate that -strands are as the major structural motifs of the
AIDA-I passenger domain (271). These data are redolent of
the B. pertussis protein pertactin, which also contains repetitive
stretches and represents the largest -stranded helix known
(see below) (123). Interestingly, such repetitive structures ap-
pear to be a characteristic of proteins associated with adhesive
or receptor functions, e.g., mycobacterial heparin-binding
haemagglutinin adhesin (392), matrix-binding proteins of
Staphylococcus aureus (190), and FHA of B. pertussis (233).
In an attempt to define the role of Aah, Benz, and Schmidt
made mutations in the aah gene (28). In the absence of Aah,
the ability of AIDA-I to confer the DA phenotype on E. coli
C600 was abolished. In addition, Western blot experiments
revealed that AIDA-I migrated with an observed molecular
mass of 80 kDa, similar to the predicted value for the pas-
senger domain, although the ability of the antisera to detect
AIDA-I was severely diminished. These data suggested that
during or after secretion, AIDA-I undergoes further posttrans-
lational processing which is dependent on Aah. In silico exam-
ination of the Aah protein revealed that it was homologous to
TibC, a protein involved in the glycosylation of another auto-
transporter protein termed TibA (292). In addition, both pro-
teins had similarity to the consensus sequence of heptosyltrans-
ferases (28). For a long time, protein glycosylation was thought
to be restricted to the realm of eukaryotes since it was assumed
that prokaryotes lacked the necessary complexity and machin-
ery for glycosylation to occur. However, research in recent
years has demonstrated that glycosylation is a frequent occur-
rence in archaea and eubacteria and that these glycosylated
proteins often play vital roles in the life-styles of the various
organisms that synthesize these moieties (325, 331). Utilizing a
glycan detection assay, it was demonstrated that the mature
AIDA-I protein possessed a carbohydrate modification. The
carbohydrate composition was determined to be 10.7% and
consisted solely of monosaccharide heptose residues at a ratio
of 19:1 (heptose molecules to AIDA-I). The position or motif
at which glycosylation occurs remains to be determined, but
intuitively the region most likely to be glycosylated is the re-
petitive region, perhaps the conserved VXNSGG (28). The
occurrence of the glycosylation phenomena for AIDA-I and
TibA suggests that this may be a much more widespread phe-
nomenon than previously thought and that such a modification
may occur frequently among the autotransporter proteins. In-
terestingly, the TibC and Aah proteins were demonstrated to
be functionally interchangeable, which suggests another level
of functionality, in that these proteins may be able to glycosyl-
ate other proteins within the cell (337).
Using HeLa cells as a model system, the receptor for
AIDA-I was recently identified (271). Protease treatment and
periodate oxidation of HeLa cells revealed that the receptor
was proteinaceous. Biotinylation in conjunction with coimmu-
noprecipitation experiments utilizing specific anti-AIDA-I an-
tisera revealed that the receptor was a 119-kDa protein. Treat-
ment of HeLa cells with various glycosidases revealed that the
receptor protein was N glycosylated. A variety of methods were
utilized to no avail in an attempt to extract the glycoprotein
receptor from HeLa cells, indicating that the protein does not
have a loose association with the cell surface. In addition,
treatment with GPI-anchor specific phopholipase (PI-PLC)
suggests that the receptor is not a GPI-anchored protein. The
cumulative data suggest that the receptor for AIDA-I is an
integral membrane glycoprotein (termed gp119) whose iden-
tity remains elusive to date (271).
Although AIDA-I is the prototypical member of this sub-
family of autotransporters, and it is from this protein that the
family derives its name, it has a surprisingly sparse distribution
among the diffuse-adhering strains of E. coli (25, 29, 435, 436).
Such data, coupled with the fact that AIDA-I-specific antisera
recognize protein species from other DAEC strains which do
not hybridize with an AIDA-I gene probe, suggests that the
DAEC pathotype of E. coli may be more complex than previ-
ously thought and that other autotransporter proteins homol-
ogous to AIDA-I may have the ability to confer a diffuse-
adhering pattern of adherence on E. coli. Interestingly, a
recent study demonstrated a relationship between the presence
of AIDA-I, F18, and stx2e in E. coli isolates from pigs diag-
nosed with edema disease and postweaning diarrhea (354).
Antigen 43
During the 1970s there was intense interest in the architec-
ture of the inner and outer membranes of E. coli. In what could
be considered the first proteomic experiments, several re-
searchers attempted to identify the complement of proteins
present in each membrane by using a variety of techniques
such as SDS-PAGE and crossed immunoelectrophoresis (Fig.
7). It was in one such study of the E. coli cell envelope that the
protein antigen 43 (Ag43) was discovered (371, 372). The ter-
minology for this protein arises from the fact that antigen 43
was the 43rd antigen in the crossed immunoelectrophoresis
profile of membrane vesicles prepared from E. coli (Fig. 7). As
such, antigen 43 was one of the first autotransporters identi-
fied, however, it was not until much later that its mode of
biogenesis was uncovered (204). In the intervening period,
much time was invested in the biochemical characterization of
this protein; Owen and coworkers (54, 370) demonstrated that
antigen 43 existed as a bipartite complex of two proteins
(termed 43 and 43) which could be resolved under denatur-
ing conditions. These subunit proteins were found to exist in a
stoichiometric fashion at a ratio of 1:1, and the interaction
between the two proteins was noncovalent. Further investiga-
tion revealed that 43 was a surface-localized protein which
could be released from the cell surface on brief heating to
60°C. In contrast, 43 was an integral outer membrane protein.
Later, Henderson and Owen (204) demonstrated that the 43
and 43 subunits represented the passenger domain and -do-
main of an autotransporter, respectively.
For many years the function of antigen 43 (Ag43) remained
elusive. Although the presence of two RGD motifs, which are
associated with binding of the homologous FHA protein to
integrins, suggested a role in adhesion, no definitive adherence
phenotype could be demonstrated (13, 204). Recently, Hen-
derson et al. (199) demonstrated that expression of Ag43 was
responsible for a flat, frizzy, and irregular colonial morphology
whereas cells not expressing antigen 43 formed glossy, circular
colonies. This variation is distinct from the similar transitions
associated with smooth and rough forms of LPS (199) and
from expression of type 1 fimbriae (191). Furthermore, antigen
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43 expression was also shown to mediate autoaggregation of
bacterial cells by mediating a cell-cell interaction (199); in-
deed, Ag43-mediated aggregation was blocked by type 1 fim-
brial expression, presumably by steric hindrance (191). Inter-
estingly, expression of Ag43 in other species allowed the
formation of inter- and intraspecies cell aggregation (250, 251).
Recent investigations have demonstrated that the ability of
Ag43 to mediate cell-cell interactions contributes to E. coli
biofilm formation in minimal media (88), and microarray ex-
periments have revealed that Ag43 expression was significantly
higher within the biofilm than at any stage of planktonic
growth (437). Interestingly, Ag43 was also demonstrated to
facilitate , P1, and T4 phage infection of E. coli (150), raising
the possibility that phage therapy could be used for certain E.
coli-mediated diseases (526).
Unlike other members of the AIDA subfamily, Ag43 ap-
pears to have a ubiquitous distribution in E. coli, existing in the
same form as prototypical Ag43 described above or as one of
several immunologically cross-reactive proteins with slightly
different molecular weights (6, 373, 421). Furthermore, many
strains were found to possess multiple copies of Ag43. Signif-
icantly, multiple copies were found associated only with patho-
genic isolates of E. coli (421). Recently, Torres et al. (493)
described the Ag43 homologue (Cah) of E. coli O157:H7. The
homologue demonstrated 69% identity to that described by
Henderson and Owen (204); however, most of the difference
could be attributed to a small truncation around the area of 43
and 43 cleavage. Furthermore, these researchers revealed that
Cah was a calcium-binding protein which also mediated auto-
aggregation and biofilm formation (493). Electrospray mass
spectrometry analysis of the purified Ag43 passenger domain
revealed that, unlike Cah, Ag43 was not postranslationally
modified or bound by any cofactors (204).
In contrast to other characterized autotransporters, Ag43
demonstrates a complex epigenetic and heritable phase varia-
tion mechanism which involves the alternative activation and
repression of agn43 transcription (200) (Fig. 7). Such phase-
variable expression has been noted for other surface-expressed
FIG. 7. Phase-variable expression of antigen 43. (A) Crossed-immunoelectrophoresis profile of Triton X-100–EDTA-extracted E. coli mem-
brane vesicles. This represents the first resolution of the antigen 43 complex. (B) Coomassie blue-stained SDS-PAGE profile of outer membrane
proteins from antigen 43-expressing and nonexpressing variants of E. coli. (C and D) Fluorescence microscopy of antigen 43 phase ON (Ag43)
and phase OFF (Ag43) populations of E. coli, respectively. (E) Expression of antigen 43 induces bacteria to autoaggregate and thus to settle to
the bottom of the growth vessel. The identity of antigen 43, its 43 and 43 subunits, and expressing and nonexpressing variants are depicted by
arrowheads and appropriate labels. (Panels A, B, and E, copyright Peter Owen and Mary Meehan.)
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proteins, although the mechanisms of regulation are quite var-
ied (205); however, all give rise to a phenotypically heteroge-
neous population. The rate of variation was calculated to be
2.2  103 Ag433Ag43 and 1  103 Ag433Ag43
(373). Screening of various mutations in a variety of regulatory
genes revealed that all cells in an oxyR mutant background
expressed Ag43. OxyR is a positive global regulator of genes
transcribed under conditions of oxidative stress. In contrast,
all cells in a dam mutant population had an Ag43 pheno-
type (204). Further investigations revealed that OxyR acts as
a repressor, binding to a region downstream of the agn43
transcriptional start site in an area which encompasses three
5-GATC-3 sites (180, 521). This binding prevents the tran-
scription of agn43 and results in an Ag43 phenotype. The
5-GATC-3 sites are susceptible to DNA methylation by Dam
(deoxyadenosine methylase). Methylation of these sites was
shown to prevent OxyR binding, and thus agn43 transcription
could occur, resulting in an Ag43 phenotype (521). More-
over, Ag43 phase variation was found to be coordinately reg-
ulated with type 1 fimbrial expression (437).
IcsA
IcsA is one of the most notorious autotransporter proteins,
being an absolute requirement for Shigella-mediated diarrhea.
The wealth of information generated about the mechanism of
IcsA action is too capacious to review in detail here; however,
it is worth noting some of the seminal characteristics of IcsA
action.
IcsA was first described by Makino et al. (309) and anno-
tated as VirG. These researchers found that mutants with a
Tn5 insertion in a region on the large virulence plasmid were
avirulent and, while capable of initially invading and multiply-
ing in epithelial cells, were unable to move intercellularly and
to infect adjacent cells. The mutation was localized to a 4-kb
gene, and sequences hybridizing to this region were found in
all Shigella and enteroinvasive E. coli strains (283, 309). Se-
quencing revealed that this gene possessed the characteristic
features of an autotransporter (283). Further evidence for the
essential nature of icsA in the pathogenesis of Shigella infection
arose from human and animal experiments which indicated
that icsA mutants were greatly attenuated (31, 265, 283, 432)
and caused smaller ulcerations and abscesses in the intestinal
mucosa (432).
In contrast to other autotransporters, which show an equal
distribution of expression over the cell surface, expression of
IcsA is localized to the old pole of the bacterium (63, 417).
Once the molecule is inserted at the old pole, the passenger
domain is cleaved from the bacterial cell surface by a specific
protease, IcsP (451). In addition, once expressed at the pole,
IcsA undergoes lateral diffusion such that the level of IcsA
forms a gradient with the highest density at the pole and de-
creasing in density as it moves away from the pole (417). The
region of IcsA responsible for directing the polar localization
of the protein was localized to the passenger domain (118).
However, recent data suggest that while IcsA is located pre-
dominantly on polar regions of the cell, it is also located lat-
erally but the O-antigen side chains mask the laterally located
molecules (339, 503).
Polar localization of IcsA results in actin accumulation at the
pole of the organism. Actin forms the scaffold of the supportive
structures of the cell, providing three-dimensional structure
and permitting cells to adopt different shapes and certain types
of movement (165). Accumulation of actin by IcsA leads to
intracellular motility of Shigella spp. and formation of an actin
tail (Fig. 8). In addition, this motility allows intercellular move-
ment, by allowing the cells to breach the membranes separat-
ing adjacent cells. That IcsA is essential and sufficient for such
motility has been demonstrated by several experiments show-
ing that (i) mutants with mutations in icsA did not develop
actin tails, (ii) E. coli strains expressing IcsA condense actin
and demonstrate motility, and (iii) inert particles coated with
IcsA exhibit actin-based motility (167, 256). The region of IcsA
responsible for the actin-based motility was localized to the
passenger domain of the protein.
Recently, the mechanism by which IcsA accumulates actin at
the old pole, thus causing motility, has been reviewed in detail
(165). In summary, IcsA appears to recruit a protein termed
N-WASP to the bacterial cell surface, disrupting intramolecu-
lar bonds and thereby activating the N-WASP proteins. The
activated N-WASP protein stimulates actin assembly via the
Arp2/3 complex. In addition to N-WASP and the Arp2/3 com-
plex, actin tail assembly requires the VASP, vinculin, profiling,
cofilin, and Cdc42 proteins. The exact role of these proteins in
actin tail assembly and motility remains to be determined (165).
TibA, ShdA, and MisL
The remaining three characterized members of the Aida
subfamily of autotransporters include TibA from enterotoxi-
genic E. coli (ETEC) and ShdA and MisL from S. enterica.
ETEC strains are capable of adhering to and invading cells
derived from the human ileocecum and colon. Two distinct
FIG. 8. IcsA-mediated Shigella motility. Fluorescence microscopy
demonstrating that IcsA (red label) is expressed preferentially at one
pole of the bacterium, where it mediates actin (green label) polymer-
ization and formation of the characteristic comet tails. The actin comet
tails are indicated by white arrowheads, and the Shigella bacterium is
indicated by a black arrowhead. (Copyright Marcia B. Goldberg.)
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chromosomal loci (tia and tib) which are responsible for the
invasion have been identified in ETEC (121, 122). Interest-
ingly, when screened against a panel of pathogenic and non-
pathogenic E. coli strains and other members of the Enterobac-
teriaceae, a tib probe hybridized only with ETEC strains,
detecting the tib locus in 30% of ETEC strains and, surpris-
ingly, showing a direct correlation with the presence of the
plasmid-encoded fimbrial adhesin CFA/I (292). In silico anal-
yses of the tib locus revealed two genes necessary for the
invasion phenotype, e.g., tibA and tibC (291, 292). As men-
tioned above, the protein encoded by the tibC gene demon-
strated homology to the RfaQ heptosyltransferase whereas
TibA demonstrated homology to AIDA-I and possessed all the
features of an autotransporter protein. In contrast to AIDA-I,
TibA possesses two repetitive regions; one region is similar to
AIDA-I, but the second shows a high level of proline residues
like the pertactin protein (292). Such proline-rich regions have
been implicated in weak nonstoichiometric binding activity
(534). Expression and mutagenesis studies of the tibA gene
demonstrated that it encoded a 104-kDa membrane protein
which was directly responsible for the ability of ETEC to in-
vade cells; chromosomal deletion mutants invaded cells at 15%
of the wild-type level, and the full level of invasion could be
restored by trans-complementation of the mutant (122). En-
zyme-linked immunosorbent assays with purified TibA dem-
onstrated that the protein was capable of binding to cultured
HCT8 ileocecal cells in a specific and saturable manner and
that this binding could be inhibited by anti-TibA polyclonal
antibodies (291). Mutagenesis studies combined with perio-
date oxidation analyses of TibA and TibC demonstrated that
TibC played a role in the glycosylation of TibA; thus, TibA was
the first glycoprotein to be described in E. coli (291, 292).
Furthermore, abolition of glycosylation also abolished the abil-
ity of TibA to direct adherence and invasion (291). The current
dogma suggests that enterotoxins are the primary agents re-
sponsible for the water loss associated with ETEC infections.
Thus, one may hypothesize that the role of TibA is to provide
intimate contact with host cells in order to allow effective
delivery of the toxin. Alternatively, TibA may contribute to
ETEC pathogenesis through an undefined mechanism.
In a recent study, Kingsley et al. (249) identified an S. en-
terica Mud-Cam mutant in a chick virulence assay. Character-
ization of this mutant revealed that the insertion was present in
a gene termed shdA and that the locus carrying shdA was
inserted in the xseA-yfgK region relative to the E. coli K-12
chromosome (249). Sequencing of this region and flanking
DNA revealed a pathogenicity island (PAI) of 25 kb, recently
designated the CS54 island, which contained several genes
including shdA, ratA, ratB, sivI, and sivH (247). In silico anal-
yses of shdA demonstrated that the protein encoded by this
gene possesses all the features of an autotransporter protein
and has homology to AIDA-I, TibA, and another S. enterica
autotransporter protein termed MisL (see below) (249). Like
AIDA-I and TibA, ShdA possesses imperfect amino acid re-
peats in the passenger domain. However, ShdA contains three
distinct repeats, three copies of a 102-amino-acid repeat, nine
copies of a 63-amino-acid repeat, and four copies of a proline-
and glycine-rich 12-amino-acid repeat which, as mentioned
previously, is a feature reminiscent of other adhesins (249). To
assess the role of ShdA in virulence, a well-defined S. enterica
servor Typhimurium mutant was constructed by allelic ex-
change and analyzed in the BALB/c murine model of infec-
tion. Results of these experiments demonstrated that ShdA
is essential for S. enterica serovar Typhimurium colonization
of the cecum and that inactivation of shdA causes a reduc-
tion in bacterial number and the length of time for which
bacteria are shed in murine feces (248, 249). Interestingly,
the cecum appears to represent the main reservoir for S.
enterica serovar Typhimurium during infection in mice
(248). Recently, Kingsley et al. demonstrated that an ShdA–
glutathione S-transferase fusion bound fibronectin in vitro
and that this binding was dose dependent and partially in-
hibited by antifibronectin antibodies (248). Furthermore,
using fluorescence microscopy and antibodies to the S. en-
terica serovar Typhimurium O-antigen, ShdA, and fibronectin,
these investigators demonstrated that all three factors colocal-
ized in the murine cecum, strongly suggesting that fibronectin
is a receptor for ShdA binding (248). However, antifibronectin
antibodies did not completely abolish binding of ShdA, leaving
the possibility that other receptors may also play a role in
ShdA-mediated adherence.
Interestingly, Southern hybridizations revealed that shdA
was associated only with S. enterica subspecies I; serotypes of
S. enterica subspecies II to VII and S. bongori do not possess
shdA (249). Serotypes derived from subspecies I differ from the
other serotypes with regard to animal reservoir since members
of subspecies I are associated with disease in warm-blooded
animals while the other serotypes are associated with disease in
reptiles. The prevalence of shdA is in contrast to previously
identified virulence factors such as SPI1, SPI2, agf, lpf, and fim,
all of which show a distribution outside of the subspecies I
lineage (249). Furthermore, virulence factors which are
known to be restricted to subspecies I show a limited distribu-
tion within the lineage whereas shdA appears to be universally
(97%) distributed (249). These data suggest that acquisition of
shdA occurred at the time of expansion of the S. enterica host
range into warm-blooded animals. Indeed, shdA may be respon-
sible for the persistence of S. enterica within warm-blooded
animals and the food chain.
MisL is also encoded by S. enterica subspecies I, but in
contradistinction to ShdA, MisL also shows a limited distribu-
tion among strains of other lineages (35). MisL is encoded on
the SPI-3 PAI, which contains genes required for intramac-
rophage survival, virulence in mice, and growth in low-Mg2
media (35). While MisL demonstrates homology to AIDA-I,
ShdA, and several other adhesins, little knowledge has been
gained about the function of this protein. An S. enterica serovar
Typhimurium misL-lac fusion did not demonstrate any expres-
sion under conditions of laboratory growth. Furthermore, a
misL mutant exhibited wild-type levels of invasion of epithelial
cells and survival within macrophages. In addition, a misL
mutant was as efficient as the parental strain in its ability to
cause a lethal infection in the BALB/c murine model (35).
These data led researchers to designate MisL a pseudogene.
However, it remains possible that MisL could be involved in
other aspects of infection such as persistence or perhaps host
specificity. Indeed, MisL could also play a role in the S. enterica
life-style which is unrelated to infection.
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AutA and AutB
AutA, a 68.3-kDa protein, was identified as a putative au-
totransporter protein by using a combined genetic and immu-
nological approach designed to detect potent CD4 T-cell-
stimulating proteins (3). AutA, which shows homology to
AIDA-I, was shown to be a strong T-cell-stimulating protein,
both for T cells taken from patients convalescing from menin-
gococcal disease and for healthy adults. Furthermore, AutA is
constitutively expressed and was expressed in all 22 strains
examined, which belonged to different serogroups. Impor-
tantly, antibodies were demonstrable in all patients who were
infected with different meningococcal strains. Thus, AutA is
consistently expressed in vivo and may play a role in the patho-
genesis of N. meningitidis. In addition, as a vaccine component
it is possible that AutA not only may act as a helper T-cell-
stimulating carrier of other vaccine targets but also may be a
helpful primary target for neutralization of its potential role in
meningococcal virulence (3).
AutB, which shows homology to AutA and appears to have
been transferred to pathogenic neisseriae from a virulent strain
of H. influenzae, is predicted to be a phase-variable outer mem-
brane protein due to the presence of tetranucleotide repeats at
the 5 end of the gene. Although a strain survey suggested that
AutB may not be expressed in meningococci (and may be a
pseudogene) (3), further evaluation is required to clarify this
and exclude expression of this protein in a subset of strains or
in vivo during infection.
CLUSTERS 5 AND 8: SERINE PROTEASE
AUTOTRANSPORTERS
IgA1 Proteases
Specific immunologic defense on mucosal surfaces is medi-
ated primarily by immunoglobulins of the IgA isotype. IgA
appears to be involved in several defense mechanisms, includ-
ing the inhibition of microbial adherence and the neutraliza-
tion of bacterial toxins and viruses. At the beginning of the
1970s, Plaut and coworkers found that IgA is degraded by
some bacterial enzymes (323, 396–400). Later, this event was
implicated as an evasion mechanism of immune responses
(398). The bacterial enzymes were called IgA1 proteases, since
they were first reported to attack only immunoglobulins of the
human IgA1 isotype, cleaving one of the peptide bonds lying
within the replicated hinge region segment of the IgA1 heavy
chain to yield intact Fab and Fc fragments (240, 401). Hu-
man IgA2 proteins are resistant to these enzymes because the
hinge region of their heavy chains has a primary sequence
deletion that involves most of the protease-susceptible peptide
sequence found in IgA1.
IgA1 proteases are extracellular proteolytic enzymes pro-
duced by major bacterial pathogens including N. gonorrhoea
and N. meningitidis, H. influenzae, Streptococcus pneumoniae,
S. sanguis, and some members of the resident oral and pha-
ryngeal microflora (240, 260, 396, 406). Three different classes
of proteases are represented among the IgA1 proteases: the
IgA1 proteases of Haemophilus and Neisseria are genetically
related serine proteases (300), those of S. sanguis and S. pneu-
moniae are metalloproteases (162), whereas studies using spe-
cific inhibitors indicate that the IgA1 protease produced by
Prevotella melaninogenica is a cysteine protease (340). Since
IgA1 proteases are all postproline endopeptidases but clearly
belong to three different families, it appears that the cleavage
of human IgA1 is a property that has evolved among bacteria
through convergent evolution following at least three indepen-
dent lines (406).
IgA1 proteases from N. gonorrhoeae and N. meningitidis are
inhibited by human secretory IgA and serum (161). This last
observation could be related to the fact that both proteases are
genetically related serine proteases. Halter et al. (185) cloned
the gene encoding the IgA protease of N. gonorrhoeae MS11.
This clone secretes IgA protease to a similar extent to the
parental MS11 strain. These authors identified a 105-kDa pro-
tein as the extracellular form of gonococcal IgA1 protease, but
by exonucleolytic digestion of the cloned insert they obtained a
fragment of 4.6 kb which could not be shortened further with-
out loss of IgA protease expression and, as mentioned previ-
ously, was later demonstrated to contain the region encoding
the translocating unit (401).
H. influenzae, N. meningitidis, and N. gonorrhoeae are all
major causes of morbidity and mortality, which have in com-
mon the secretion of IgA1 proteases. The IgA1 proteases of
the three species are all serine protease autotransporters (17),
which specifically attack one of several Pro-Ser or Pro-Thr
peptide bonds within the duplicated octapeptide in the hinge
region of IgA1 (243, 343) and possess the consensus sequence
GDSGSPLF, where S is the active-site serine characteristic of
serine proteases (17).
The exact peptide bond cleaved by IgA1 proteases of the
three species differs among strains. While H. influenzae strains
cleave either the Pro231-Ser232 (type 1 protease) or the Pro235–
Thr236 (type 2 protease) bonds in human IgA1, Neisseria IgA
proteases cleave Pro235-Thr236 (type 2 protease) or Pro237-
Ser238 (type 1 protease). Cloning and sequencing of the IgA1
protease gene (iga) from N. meningitidis showed an overall
structure equivalent to that of iga genes from N. gonorrhoeae
and H. influenzae, although no region corresponding to the
gonococcal -peptide was evident (300). Moreover, the epi-
topes that are recognized by enzyme-neutralizing antibodies
show a remarkable heterogeneity among H. influenzae (243,
301) and N. meningitidis IgA1 proteases (299).
Cleavage of intact IgA1 (or S-IgA1) results in the loss of
Fc-mediated secondary effector functions, such as inhibition
of adherence (184), despite the retention of antigen-binding
activity by the Fab fragments (312). Further, it has been
hypothesized that Fab fragments may simultaneously block
the binding of intact (functional) antibodies of IgA or other
isotypes to bacterial epitopes (241) and thereby inhibit com-
plement activation and bacteriolysis (225, 426). Plaut et al.
(399) have found that milk antibodies neutralizing serine-type
IgA proteases interfered with the autoproteolytic mechanism
of release of these enzymes and that IgA1 protease molecules
consequently persisting on the cell surface provided for anti-
body-mediated agglutination of the bacteria. Thus, cell-bound
and secreted IgA1 protease may play distinct roles in vivo.
Several other lines of indirect evidence for a role in pathogen-
esis have been reported: nonpathogenic species of Neisseria
and Haemophilus lack IgA1 protease activity (242, 342); the
products of IgA1 cleavage have been found in the cerebrospi-
nal fluid of patients with bacterial meningitis, in vaginal wash-
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ings from patients with gonorrhea, and in other secretions
from individuals infected with known IgA protease-producing
bacteria (2, 244).
Despite these functions ascribed to the IgA1 protease, its
role in pathogenesis remains enigmatic. A recent human chal-
lenge study showed that an iga mutant was not impaired in its
ability to initiate an infection in the human male urethra (228).
However, since infection in this study was terminated at the
onset of urethritis, a role for IgA1 protease in initial coloniza-
tion, in establishing invasive complications such as pelvic in-
flammatory disease, or in contributing to reinfection of a pre-
viously exposed host cannot be ruled out. Another report
showed that the secretion of this protease seems not to be
required for the adherence and invasion of epithelial cells by
N. gonorrhoeae in vitro (72). On the other hand, IgA1 protease
activity can be inhibited by antibodies (161), and antibodies to
IgA1 protease and inhibitory antibodies have been detected in
serum and secretions from patients infected with IgA1 pro-
tease-producing organisms (48, 103). Hedges et al. (193) ex-
amined the levels of these opposing factors (IgA1 protease and
inhibitory antibodies) in genital tract secretions and sera from
women infected with N. gonorrhoeae, and their results sug-
gested that cleavage of IgA1 by gonoccocal IgA1 protease
within the lumen of the lower genital tract is unlikely to be a
significant factor in the pathogenesis of infection by N. gonor-
rhoeae.
It had been repeatedly reported that this group of enzymes
is specific for a single substrate, the hinge region of human
IgA1 (397). However, the first description of a substrate other
than human IgA1 for the gonococcal enzyme was its autopro-
teolytic event, since once exposed on the extracellular side of
the outer membrane, the proenzyme releases itself via an au-
toproteolytic event. Finally in the fluid phase, IgA1 protease
makes another cleavage in its own sequence to release the
-peptide (12 or 15 kDa). Shoberg and Mulks (454) examined
the susceptibility of isolated outer and cytoplasmic membranes
of N. gonorrhoeae to IgA1 protease in an in vitro assay system
using both wild-type gonococcal strains and IgA1 protease-
deficient variants. These authors found that the gonococcal
IgA1 protease is capable of hydrolyzing several proteins in the
outer and cytoplasmic membranes and further indicated that
this effect is neither strain nor species limited.
Binscheck et al. (33) reported a second target of the IgA1
protease in eukaryotic cells, synaptobrevin II. Like tetanus
toxin, the IgA protease cleaved synaptobrevin II, a fusion com-
plex-forming protein associated with vesicles (438), although at
a different site of the molecule, but unlike tetanus toxin, it does
not cleave cellubrevin. When IgA1 protease was introduced by
electroporation into chromaffin cells, an inhibition of the exo-
cytosis similar to that shown for tetanus toxin was observed
(33). However, the IgA protease is nontoxic for nerve cells
under physiological conditions, and this potential target is re-
stricted to defined intracellular compartments that may not
naturally be accessible by gonococci.
Several years ago, two independent groups reported that
Neisseria type 2 IgA1 protease cleaves the lysosomal/phagoso-
mal membrane protein LAMP-1 (192, 288). Lysosomal/phago-
somal membranes of mammalian cells are coated by highly
conserved glycoproteins (LAMPs) that are thought to protect
the membranes from degradation. It has been shown that in-
tracellular N. gonorrhoeae resides in the same compartment as
the human LAMP-1 (192) and that this membrane protein
contains an IgA1-like hinge region with potential cleavage sites
for the neisserial type 1 and type 2 IgA1 proteases (192, 288).
Neisserial type 2 IgA1 protease cleaves purified LAMP-1 in
vitro, and, unlike its wild-type isogenic parent, an iga mutant of
N. gonorrhoeae cannot affect LAMP-1 turnover and its growth
in epithelial cells is dramatically reduced (288). Interestingly,
IgA1 protease is much more active on LAMP-1 in cell lysates
than on purified LAMP-1. Furthermore, Hauck and Meyer
(192) demonstrated that the secreted enzyme can be active in
an acidic phagosomal microenvironment and that the IgA1
protease is capable of cleaving glycosylated human LAMP-1.
Many intracellular bacteria have developed various means of
modifying their phagosomal environments in order to avoid
lysosome killing. Thus, IgA protease cleavage of LAMP-1 pro-
motes intracellular survival of pathogenic Neisseria spp. More
recently, Hopper et al. (211) determined that the IgA1 pro-
tease also affects the trafficking of N. gonorrhoeae across po-
larized T84 epithelial monolayers. They found that N. gonor-
rhoeae infection of T84 monolayers also results in IgA1
protease-mediated reduction of LAMP-1 and that iga mutants
were impaired in their ability to traverse polarized T84 mono-
layers. These data strongly suggest that the IgA1 protease plays
a role in N. gonorrhoeae transepithelial trafficking.
Novel functions of the native IgA1 protease related to the
immune system have been reported. Lorenzen et al. (302)
studied the immunogenic and immunomodulatory properties
of the neisserial IgA1 protease. They found that IgA1 protease
acts like a modulin by stimulating the release of tumor necrosis
factor alpha (TNF-), interleukin-1 (IL-1), IL-6, and IL-8
from peripheral blood mononuclear cells but not the regula-
tory cytokine IL-10. The capacity of IgA1 protease to elicit
such cytokine responses in monocytes is enhanced in the pres-
ence of T lymphocytes, and its proteolytic activity is not re-
quired for this induction. Interestingly, these proinflammatory
cytokines have been detected in local secretions and sera dur-
ing mucosal infection with N. gonorrhoeae (193). It has been
suggested that the induction of proinflammatory cytokines may
contribute to the characteristic inflammatory reaction caused
by the pathogenic Neisseria spp. (302). TNF- plays a pivotal
role in protection against parasitic, viral, and bacterial infec-
tions, Beck and Meyer (21) therefore investigated the possible
role of neisserial IgA1 protease in TNF--dependent signaling
processes. They found an inhibition of TNF--mediated apo-
ptosis of the human myelomonocytic cell line U937 by IgA1
protease. Furthermore, they also found that IgA1 protease
specifically cleaved TNF receptor II (TNF-RII) on the surface
of intact cells whereas TFN-RI was not affected by the enzyme
(21). The modulation of programmed cell death is very impor-
tant in the pathophysiology of inflammation and infection (69),
and it has been shown that TNF receptor II activates NF-B
and induces apoptosis (189).
As mentioned previously, the gonococcal iga encodes a se-
creted -protein, which is cleaved from the C-terminal end of
the passenger domain after release into the extracellular mi-
lieu. Among the greater IgA1 protease family, the pathogenic
Neisseria species appear to be unique with regard to the pro-
duction of extracellular -protein (402). The physical linkage
of IgA1 protease and -protein suggests a functional relation-
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ship of the two precursor components. It has been reported
that -protein is essential neither for extracellular transport
nor for the proteolytic activity of IgA1 protease. Pohlner et al.
(402) have reported that the amino acid sequences are remi-
niscent of nuclear localization signals (NLS) of viral and eu-
karyotic proteins in that the -protein is functional in trans-
fected eukaryotic cells. More importantly, these authors
showed that native purified -protein is capable of entering
certain human primary cells from the exterior via an endocytic
route and accumulates in the nuclei. Additionally, neisserial
-protein shares several features with eukaryotic transcription
factors; the authors therefore propose that -protein, probably
in concert with IgA1 protease, functions in the modulation of
host cell properties.
H. influenzae Adhesion and Penetration Protein (Hap)
Nontypeable H. influenzae is a common commensal organ-
ism in the human upper respiratory tract and an important
cause of localized nasopharyngeal diseases such as otitis me-
dia, sinusitis, bronchitis, and pneumonia, in contrast to encap-
sulated strains, which cause systemic disease such as septice-
mia, meningitis, and suppurative arthritis (494). Adherence of
nontypeable H. influenzae to mammalian cells depends on the
presence of several different factors: (i) a minority of strains
express the adhesin Hia (H. influenzae adhesin), (ii) most iso-
lates express the adhesins HMW1 and HMW2 (high-molecu-
lar-weight surface-exposed proteins), and (iii) all strains con-
tain the hap gene.
Hap is a surface protein associated with the capacity for
intimate interaction with, attachment to, and entry into cul-
tured epithelial cells. This protein was identified as an addi-
tional adhesin in mutants deficient in expression of HMW1
and HMW2 or Hia (466). Hap is synthesized as a 155-kDa
protein which is localized to the outer membrane, but it is also
associated with the production of a 110-kDa extracellular pro-
tein (the passenger domain) and a second outer membrane
protein of about 45 kDa (the translocating unit). Hap has sig-
nificant homology to the IgA protease of H. influenza (60%
identity and 80% similarity). This homology includes the re-
gion identified as the catalytic site of the IgA1 proteases, which
in Hap is represented by GDSGSPMF (466). Like the IgA1
proteases, the passenger domain directs autoproteolytic cleav-
age via its intrinsic serine protease activity, releasing the pas-
senger domain into the culture supernatant; the autoproteo-
lytic cleavage occurs primarily at the peptide bond between
Leu1036 and Asn1037 (206); however, this cleavage event is not
complete, much of the secreted Hap remains uncleaved and
cell associated; there are therefore two forms of Hap, cell
associated and extracellular.
In addition to harboring serine protease activity, the Hap
passenger domain possesses the adhesive activities responsible
for bacterial-epithelial cell interaction and bacterial aggrega-
tion. Hendrixson and St Geme (207) found that the uncleaved
cell-associated form of Hap mediates adherence to cultured
epithelial cells and promotes bacterial aggregation and micro-
colony formation, whereas more recent data demonstrated an
interaction between Hap and extracellular matrix proteins
(135, 137, 138). Adherence and aggregation are augmented by
secretory leukocyte protease inhibitor, a soluble protein com-
ponent of respiratory secretions that inhibits Hap autoprote-
olysis. These data suggest that secretory leukocyte protease
inhibitor, whose primary function is to protect host epithelium,
potentiates properties that facilitate bacterial colonization.
These data also indicate that Hap serine protease activity and
release of the mature 110-kDa Hap protein are not essential
for Hap to promote interaction with cultured epithelial cells
(207). In contrast to the role of secretory leukocyte protease
inhibitor, Qiu et al. (411) have found that human milk lacto-
ferrin is able to inactivate Hap. Previous studies had already
demonstrated that human milk lactoferrin is protective against
H. influenzae colonization and disease. Human milk lactoferrin
efficiently extracts the IgA1 protease proprotein from the bac-
terial outer membrane and specifically degrades Hap and abol-
ishes Hap-mediated adherence. Extraction of IgA1 protease
and degradation of Hap were localized to the N-lobe of the
bilobed lactoferrin molecule and were inhibited by serine pro-
tease inhibitors, suggesting that the lactoferrin N-lobe may
contain serine protease activity (411).
Autoproteolytic cleavage of Hap seems counterintuitive for
a protein which promotes successful colonization and bacterial
aggregation. However, it is possible that release serves one of
several functions. Release may facilitate evasion of the im-
mune responses directed at Hap. Alternatively, autoproteolytic
cleavage of Hap at several sites on the same molecule may
release bioactive peptides, as has been documented for IgA1
protease (402). Free Hap may also interact with specific mu-
cosal IgA antibodies to avoid bacterial opsonization and en-
hance phagocytic removal. On the other hand, shedding of an
adhesive domain from the cell surface may allow individual
organisms to disperse from microcolonies or epithelial cells
and then migrate within the respiratory tract. A further possi-
bility is that release of Hap facilitates the degradation of target
host proteins such as tissue components or immune system
effectors. Interestingly, the first experiments to find a Hap-
immune system interaction have shown that Hap does not
induce proinflammatory cytokines from human respiratory ep-
ithelial cells but that immunization with the purified protein
does protect mice against nasopharyngeal colonization with
wild-type organisms (68, 86).
N. meningitidis App and MspA Autotransporter Proteins
App is a highly conserved and constitutively expressed 160-
kDa protein, is localized in the outer membrane, and is partly
secreted by autocleavage (182). The outer membrane-localized
precursor is surface accessible, and antibodies raised against
recombinant App exhibit bactericidal activity against the ho-
mologous strain (182). Recently, Serruto et al. (445) have con-
firmed that App is an important virulence determinant, which
mediates adhesion to epithelial cells (but not endothelial cells).
Indeed, App is the first nonpilus protein to be shown to possess
adhesive properties in the presence of the polysaccharide cap-
sule. Analogous to the Hap protein in H. influenzae, autocleav-
age of App may assist in the detachment and dispersal of
meningococci, allowing colonization/invasion of neighboring
epithelial cells, a phenomenon also suggested for B. pertussis
(81, 136). Taken together, these data strongly suggest that App
plays an important (and possibly indispensable) role in the
early stages of meningococcal pathogenesis in the nasophar-
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ynx. A specific and separate role for the secreted fragments of
App is also possible; as has been shown in the case of the IgA1
protease, App also possesses a helix-rich putative -protein
located between the passenger domain and the -domain. One
RGD motif is present in the App protein from the group A
strains Z3515 and Z2491; however, it was not conserved in the
sequences of the group B strains SD or MC58 or in the group
C strain Z4181. Since these motifs in autotransporters are
usually present in pairs, a single RDG motif within the App of
strain Z2491 might be fortuitous. A serine protease motif,
GDSGP, is also present and conserved in the App proteins
from all five meningococcal App sequences (182).
When whole-cell meningococcal lysates of strain MC58 were
probed with a rabbit anti-App antiserum, strong bands of 175
and 100 kDa and weaker bands of ca. 160 and ca. 140 kDa were
detected. The Hap protein has been shown to be cleaved at
several sites (206). It is likely, therefore, that the App-derived
products observed in meningococcal supernatants also result
from autocatalytic cleavage at alternatives sites; however, the
precise cleavage sites within App have not been determined.
It is interesting that App also possesses a putative NLS motif,
consisting of five or six positively charged residues preceded by
a proline residue. In App (from strain MC58), the putative
NLS motif (932PRRRSRR938) is located upstream of the pre-
dicted N-terminal autocleavage site (956F2NTL959). The na-
tive -protein from IgA1 protease, which contains NLS motifs,
was demonstrated to enter human cells and accumulate in the
nuclei, potentially influencing the regulation of host cell func-
tions (402). In addition, the arginine-rich region in App may
act as a signal for the correct localization of the downstream
autocleavage sites (182). Interestingly, a recent study has dem-
onstrated that Hap is cleaved by lactoferrin (long known for its
role in mucosal defense) following RRSR or RSRR motifs;
these motifs are also present in App and are clustered imme-
diately downstream of the putative NLS motif. The authors
therefore postulate that lactoferrin may also cleave App and,
as with Hap, reduce the biological effectiveness of the mole-
cule. An effective antibody response to App may similarly lead
to functional neutralization of the protein and thus contribute
to protection against invasive disease. The latter underlines the
importance of a functional assessment of App in relation to
vaccine potential. Finally, analogous to AutA, App was also
shown to strongly stimulate helper T cells (182).
Proteins of the size expected for App, including the secreted
form, were specifically detected by the anti-App antiserum in a
range of meningococcal isolates. In addition, the sera from
patients convalescing from invasive meningococcal disease
contained antibodies that recognized recombinant App, which
provides evidence that App is both expressed during infection
and a B-cell immunogen. Moreover, antiserum raised against
denatured recombinant App was capable of killing meningo-
cocci of the homologous strain in the presence of the comple-
ment (182). These authors also have shown that App is a
strong T-cell stimulant in several unrelated individuals, induc-
ing proliferative responses of the same magnitude as those
elicited by outer membrane vesicle vaccine for human volun-
teers (504). Nevertheless, App is conserved, is expressed dur-
ing infection and carriage, and stimulates B and T cells, and
antibodies to App are bacteriocidal (182).
MspA (meningococcal serine protease A), a recently iden-
tified and characterized autotransporter protein (D. P. J.
Turner and D. A. Ala’Aldeen, unpublished data), shows 34%
overall homology to App at the amino acid level. Like App,
MspA possesses a chymotrypsin serine protease active site and
an identical putative autocleavage site (870F2NTL873). No
function has been assigned to MspA.
Serine Protease Autotransporters of the Enterobacteriaceae
Members of the SPATE family are proteins from E. coli and
Shigella spp., which, like the IgA1 proteases and Hap, possess
a consensus serine protease motif (203). Since 1994, investiga-
tors have described SPATE members in several pathotypes of
E. coli, although their full contributions to pathogenesis are
unknown. However, these proteins possess several common
features: (i) unlike the IgA1 proteases, none of the SPATE
family has been shown to cleave IgA1, (ii) the serine protease
motif of SPATE proteins does not play a role in autoprocess-
ing, (iii) each SPATE member is among the predominant se-
creted proteins of their respective pathogens, (iv) no SPATE
has yet been identified in a nonpathogenic organism, and (v)
SPATE are highly immunogenic proteins. Interestingly, de-
spite their high levels of homology, the SPATE proteins dem-
onstrate distinct substrate specificities (113).
Tsh. In 1994, the first SPATE was described as a tempera-
ture-sensitive haemagglutinin (Tsh) in avian-pathogenic E. coli
(APEC), which causes disseminated infections in birds. Cos-
mid screening and subcloning identified a 140-kDa secreted
protein, which confers on E. coli K-12 a temperature-sensitive
hemagglutination phenotype that is best expressed when cells
are grown at 26°C (409). Conjugation and hybridization exper-
iments revealed that tsh gene is located on a ColV-type plas-
mid, near the colicin V genes, in many of the APEC strains
studied by Dozois et al. (108). The deduced amino acid se-
quence encoded by tsh was found to contain homology to four
serologically distinct H. influenzae iga genes and with N. gon-
orrhoeae IgA1 protease. Furthermore, the region of Tsh ho-
mologous to the serine-type IgA1 proteases is limited mainly to
the approximately 900 N-terminal residues of Tsh (409). Fur-
ther studies have shown that E. coli K-12 containing the re-
combinant tsh gene produces two proteins, a 106-kDa extra-
cellular protein and a 33-kDa outer membrane protein. The
Tsh passenger domain contains the 7-amino-acid serine pro-
tease motif that includes the active site serine (S259), found
also in the secreted domain of the IgA1 protease. However,
site-directed mutagenesis of this motif did not abolish the
hemagglutinin activity or extracellular secretion of Tsh. More-
over, the passenger domain did not cleave human or chicken
IgA and did not show proteolytic activity in a casein-based
assay (460).
Correlation of Tsh expression and hemagglutination activity
appears to be a very complex phenomenon, influenced by
strain and environmental conditions. Nevertheless, for both
APEC and recombinant E. coli K-12 strains containing the tsh
gene, it was only the whole bacterial cells and not the cell-free
supernatant that could confer hemagglutinin activity (460). In
addition to the temperature-sensitive phenotype, haemagglu-
tination activity is absent after growth of Tsh-positive E. coli
7122 strain on agar supplemented with 0.15 M NaCl (460).
Maurer et al. (318) examined the occurrence of ambient-tem-
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perature-regulated Tsh among avian and mammalian E. coli
isolates. Tsh was present in approximately 46% of clinical
avian E. coli isolates but was not detected among commensal
E. coli strains isolated from healthy broiler chicken. In a prev-
alence study, Dozois et al. (108) found that of the tsh-positive
APEC isolates, 90.6% belonged to the highest-virulence class.
Furthermore, they found that experimental inoculation of
chicken with 7122 and an isogenic tsh mutant demonstrated
that Tsh may contribute to the development of lesions within
the air sacs of birds but is not required for subsequent gener-
alized infection manifesting as perihepatitis, pericarditis, and
septicemia.
Recently, a novel heme-binding protein, termed the hemo-
globin-binding protease (Hbp), was characterized in an
E. coli strain isolated from a wound infection (369). Hbp is
99.9% identical to Tsh, demonstrating two nonsynonymous
changes in the amino acid sequence of the passenger domains,
neither of which appears to be present in a domain affecting
the function of the protein. Like the tsh gene, hbp is located
on a ColV-type plasmid, near the colicin V genes (108). Hbp
scavenges heme from its environment, interacts specifically
with human hemoglobin, degrades it, and subsequently binds
the released heme (369). However, purified Hbp is unable to
induce hemagglutination activity. The reason for the apparent
difference between Hbp and Tsh in hemagglutination activity
remains unclear but may be due to different culture conditions.
It seems that only under very specific conditions can hemag-
glutination activity by Tsh be detected. More recent results
suggest that the synergy of abscess formation by E. coli and
Bacteroides fragilis can be partly explained by the capacity of
B. fragilis to intercept Hbp and iron from heme and to over-
come the iron restrictions imposed by the host (368).
SepA. In 1995, Benjelloun-Touimi et al. described a Tsh ho-
mologue designated SepA (for Shigella extracellular protein),
which is the major extracellular protein of S. flexneri (22).
Investigation of the proteolytic activity of SepA utilizing a wide
range of synthetic peptides found that SepA hydrolyzed several
of these substrates and that the activity was inhibited by the
serine protease inhibitor phenylmethylsulfonyl fluoride (PMSF)
(23). Several SepA-hydrolyzed peptides were described as spe-
cific substrates for cathepsin G, a serine protease produced by
polymorphonuclear leukocytes that was proposed to play a role
in inflammation. However, unlike capthesin G, SepA degraded
neither fibronectin nor angiotensin I and had no effect on the
aggregation of human platelets.
The presence of sepA on the virulence plasmid, as well as the
recognition of SepA by the sera of monkeys infected with
Shigella, suggested that SepA might be involved in Shigella
pathogenicity (22). However, construction and phenotypic
characterization of a sepA mutant suggested that SepA is re-
quired neither for entry into cultured cells nor for intracellular
dissemination. Nevertheless, the sepA mutant demonstrated a
reduced ability to induce both mucosal atrophy and tissue
inflammation in the rabbit ligated ileal loop model, indicating
that SepA may play a role in tissue invasion, although this
hypothesis remains to be elucidated (22).
EspC. In 1996, Stein et al. (461) described EspC (for
“EPEC-secreted protein C”), the major exported protein in
the supernatants of the prototypical EPEC strain E2368/69.
However, the construction of a deletion in espC by allelic
exchange showed that EspC is not necessary for mediating
EPEC-induced signal transduction in HeLa epithelial cells and
does not play a role in adherence or invasion of tissue culture
cells (461).
Interestingly, genes homologous to espC also exist in other
pathogenic bacteria which form attaching and effacing (A/E)
lesions. However, secretion of a 110-kDa protein by these
strains was not detected. The presence of genes homologous to
espC in the pathogenic strains of bacteria that cause A/E le-
sions but not in nonpathogenic strains implies that EspC may
play a role in the virulence of A/E-inducing pathogens. A
possible function in EPEC virulence is supported by the fact
that EspC is a highly immunogenic protein. Human serum
colleted from a volunteer 28 days after infection with EPEC
strongly recognized EspC, while serum colleted prior to infec-
tion did not (226). Moreover, S-IgA antibodies purified from
Mexican women, which inhibit the adherence of EPEC to cells,
strongly reacted with a 110-kDa protein, among other proteins.
The molecular size of this protein and its reactivity with spe-
cific anti-EspC antiserum suggest that it is EspC (311).
Recently, it was demonstrated that expression of espC was
under the control of several extragenic regulators. While ex-
pression of EspC is unaffected by mutations in the genes re-
quired for assembly of the EPEC type III secretion apparatus
encoded in the locus of enterocyte effacement (LEE), expres-
sion of EspC is coregulated with secretion of type III secreted
proteins (237). This regulation was influenced by temperature,
CO2 and a positive transcriptional regulator, PerA (168, 183).
In addition, Elliott et al. (120) have found that a LEE-encoded
regulator (Ler), part of the Per-mediated regulatory cascade, is
essential for the expression of EspC as well as multiple LEE
genes.
The function of EspC in EPEC is unknown; however, it was
determined that the espC gene is located within a second
EPEC PAI at 60 min on the chromosome of E. coli. It was also
shown that EspC is an enterotoxin, as indicated by rises in
short-circuit current and potential difference in rat jejunal tis-
sue mounted in Ussing chambers. In addition, preincubation
with antiserum against the homologous Pet enterotoxin of
EAEC eliminated EspC enterotoxin activity (324). Recently,
investigations have demonstrated that coincubation of high
concentrations of EspC with epithelial cells in vitro, and over
a prolonged period, induces cytopathic effects similar to those
of Pet (348; see below).
EspP. In 1997, almost simultaneously Brunder et al. (49)
described EspP (for “extracellular serine protease plasmid-en-
coded”) and Djafari et al. (106) described PssA (for “protease
secreted by STEC”) in EHEC O157:H7 and Shiga-toxin pro-
ducing E. coli (STEC) O26:H, respectively. These proteins
are identical, are encoded on the large virulence plasmids, and
represent the major extracellular proteins of both organisms.
Similar to other SPATE, the genes (espP and pssA) gave rise to
processed 104-kDa mature extracellular proteins.
Hybridization experiments and immunoblot analysis of clin-
ical EHEC isolates showed that EspP is widespread among
EHEC of the serogroup O157 and that it also exists in sero-
group O26, while antibodies against PssA from STEC O26:H
detected PssA in three human STEC isolates (O157:H7, O157:
H, and O157:H) and in strains 332 (O26:H) and 570/89
(O111:H). On the other hand, both proteins are highly im-
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munogenic and have been detected in sera from patients
(49, 106). Interestingly, different biological activities were
described for EspP and PssA. EspP is a protease capable of
cleaving pepsin A and human coagulation factor V (when
present in serum but not in its purified form), suggesting that
degradation of factor V could contribute to the mucosal hem-
orrhage observed in patients with hemorrhagic colitis (49),
whereas, PssA-showed serine protease activity in a casein-
based assay and is cytotoxic for Vero cells, suggesting a func-
tional importance during infection of the mucosal cell layer by
the bacterial pathogen (106).
Pet. In 1998, a heat-labile enterotoxin from EAEC was de-
scribed as a secreted 108-kDa protein encoded in the EAEC
virulence plasmid; it was recognized by sera from children who
were infected during an outbreak of diarrhea in a pediatric
ward of a Mexican hospital (125, 349). The genetic character-
ization of this high-molecular-mass heat-labile toxin demon-
strated that it represented the passenger domain of a 140-kDa
autotransporter precursor which was termed Pet (124). Several
lines of evidence support a role for this protein in mediating
enterotoxic activity. Thus, this enterotoxin produced tissue
damage characterized by increased mucus release, cell exfoli-
ation, and crypt abscesses in rat jejunum (349). Furthermore,
purified Pet raised the short-circuit current and decreased the
electrical resistance of rat jejunum mounted in an Ussing
chamber, an effect that is indicative of mucosal damage (349).
Finally, in vitro organ experiments with human intestinal mu-
cosa demonstrated that a mutant with a null mutation in the pet
gene was unaffected in its ability to adhere to colonic tissue but
was unable to elicit the characteristic mucosal changes ob-
served with the wild-type parental strain (Fig. 9). The effects
were restored by trans-complementation of the pet gene (196,
197).
While investigating its mode of action, Navarro-Garcia et al.
(350) found that Pet induces temperature-, time-, and dose-
dependent cytopathic effects on HEp-2 and HT29/C1 cells.
Furthermore, Pet appears to be a cytoskeleton-altering toxin
since it induces contraction of the cytoskeleton, loss of actin
stress fibers, and release of the cellular focal contacts in cell
monolayers, followed by complete cell rounding and detach-
ment. Pet cytotoxicity and enterotoxicity depend on Pet serine
protease activity, since both effects are inhibited by PMSF and
are not induced by Pet S260I, which is mutated in a predicted
serine protease motif and thereby lacks in vitro protease ac-
tivity on zymogram gels (350).
Recently, it has been reported that Pet enters HEp-2 cells
and that this internalization is required for the induction of
cytopathic effects and is mediated by a domain within the
central region of the passenger protein (114, 347, 513). Fur-
ther, Pet trafficking appears to occur through a retrograde
transport mechanism since brefeldin A prevents the cytopathic
and cytoskeletal effects observed when cells are treated with
native Pet. Moreover, while native Pet and Pet S260I can be
observed by confocal microscopy inside the epithelial cells and
while recent data obtained using alanine scanning-linker mu-
tagenesis have shown that the proteolytic site was necessary for
toxicity, only native Pet is able to produce the cytoskeletal
effects, indicating that the target protein for Pet is an intracel-
lular moiety (114, 347). Indeed, Pet is capable of cleaving
spectrin of erythrocyte ghosts, purified spectrin, and fodrin
(nonerythroid spectrin) from HEp-2 cells. This processing ef-
fect was inhibited by PMSF and was not observed for the Pet
S260I mutant (513). In further support of this work, Sui et al.
(473) demonstrated spectrin condensation when the Pet func-
tional domain was expressed intracellularly. In fact, experi-
ments in Navarro-Garcia’s laboratory show that Pet is able to
cleave recombinant fodrin fused to glutathione S-transferase
(109 kDa), and this effect correlated with dose-dependent re-
distribution of fodrin in HEp-2 cells. Moreover, Pet has an
affinity for fodrin as demonstrated by overlay and colocaliza-
tion experiments (55). Pet is able to cleave fodrin between
M1198 and V1199 in helix C and inside of the calmodulin-
binding domain. Such effects and fodrin redistribution in
HEp-2 cells were prevented by using the Pet S260I mutant or
PMSF (56). Fodrin cleavage as the primary mode of action
could account for the cellular changes induced by Pet toxin,
since fodrin is one of the main protein components of the focal
adhesion complex. In addition, several membrane channels are
linked to the fodrin network (104), and therefore cleavage of
fodrin could explain the enterotoxic effects of Pet as well (Fig.
9).
Pic. A second SPATE member was identified in EAEC. This
protein was recognized by the sera from the same children who
were infected during an outbreak of diarrhea in a paediatric
ward of a Mexican hospital and which were used to identify Pet
(125, 349). In contrast to Pet, Pic is localized in the EAEC
chromosome. Henderson et al. (196) found that Pic was iden-
tical to a protein termed Shmu (Shigella mucinase), which is
encoded on the Shigella she PAI (412). Interestingly, the pic
gene has an unique characteristic among the autotransporter
proteins since within the pic (she) gene there are two oppo-
sitely oriented genes, set1B and set1A (196, 412), in tandem,
which encode the 7- and 20-kDa subunits of the 55-kDa ShET1
toxin (131). The sequences flanking pic are different in EAEC
and S. flexneri; in the case of S. flexneri, the she PAI contains
another SPATE, SigA, which is similar to Pet (see below).
Pic catalyzes gelatin degradation; degradation can be abol-
ished by disruption of the predicted proteolytic active site.
Functional analysis of Pic implicates this factor in mucinase
activity, serum resistance, and hemagglutination. Phenotypes
identified for Pic suggest that it is involved in the early stages
of pathogenesis and most probably promotes intestinal coloni-
zation (196). Recently, a homologue, PicU (96% identity at the
amino acid level), with similar functions has been character-
ized in uropathogenic E. coli (381). Subsequent investigations
by Heimer et al. (194) revealed that picU was expressed during
experimental infection in the mouse model of urinary tract
infection. However, cochallenge of wild-type organisms and
the picU mutant in the mouse model suggested that PicU-
encoding strains had no competitive advantage in colonization
(194). Nevertheless, since PicU is a secreted protease, it is
possible that protein secreted by the wild-type strains may
complement the picU deficiency of the mutant strains. Indeed,
challenge of mice separately with wild-type and picU mutant
strains revealed that the wild type colonized the bladder to a
greater extent and displayed higher levels of neutrophil infil-
tration into the lumen, epithelium, and submucosa. Unfortu-
nately, while these data showed a trend, they were not statis-
tically significant (P  0.2) (194). In addition, it should not be
discounted that loss of PicU function may be complemented by
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FIG. 9. Activity of the EAEC Pet toxin. (A and B) Internalization of Pet (A) and a serine protease motif mutant (Pet S260I) (B) into HEp-2
cells. HEp-2 cells were treated with either Pet or Pet S260I for 1 h. The actin cytoskeleton is labeled with green, and Pet or Pet S2601 is labeled
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the homologous Vat and Sat serine protease autotransporters
(see the discussions of these proteins). Thus, the role of PicU
in uropathogenic E. coli infection remains enigmatic.
SigA. An initial report showed that the she PAI, which con-
tains the pic (she) gene, also contains a gene encoding a second
IgA protease-like homologue, sigA, lying 3.6 kb downstream
and in an inverted orientation with respect to pic (412). Func-
tional analysis showed that SigA is a secreted temperature-
regulated serine protease capable of degrading casein. Per-
forming similar experiments to those used with Pet revealed
that SigA is cytopathic for HEp-2 cells, suggesting that it may
be a cell-altering toxin with a role in the pathogenesis of Shi-
gella infections. Furthermore, SigA was at least partly respon-
sible for the ability of S. flexneri to stimulate fluid accumulation
in ligated rabbit ileal loops (5).
Sat. Uropathogenic E. coli CFT073, a strain cultured from
blood and urine of a patient with acute pyelonephritis, ex-
presses a 107-kDa protein named Sat (for “secreted autotrans-
porter toxin”), which is expressed more often by E. coli strains
associated with the clinical syndrome of acute pyelonephritis
than by fecal strains (178). Like Pet, Sat exhibited serine pro-
tease activity and displayed cytopathic activity on Vero primary
kidney, HK-2 bladder, and HEp-2 cells lines (178). Further
investigations revealed that Sat triggered the vacuolation of
both human bladder (CRL-1749) and kidney (CRL-1573) cell
lines. Using a mouse model of transurethral infection, Guyer
et al. demonstrated that a sat mutant was similar to wild-type
E. coli CFT073 in colonization of the urine, bladder, and kid-
ney tissue. In contrast, in mice infected with wild-type E. coli
CFT073, dissolution of the glomerular membrane and vacuo-
lation of proximal tubule cells could be observed, while no such
effects were seen in kidney sections from mice infected with a
sat null mutant, suggesting that Sat contributes to the patho-
genesis of urinary tract infection by eliciting damage to the
kidneys during upper urinary tract infection (179).
Vat. Recently, it was reported that certain APEC strains
induced vacuolating cytotoxic activity similar to that induced
by the H. pylori autotransporter protein VacA (427) (see the
following sections). Subsequently, Parreira and Gyles (384)
identified a gene encoding a serine protease autotransporter
protein (Vat), which was responsible for the vacuolating activ-
ity of a strain of E. coli (Ec222) that had been isolated from a
septicemic chicken. Further investigations revealed that this
gene was required for the virulence of E. coli Ec222, since a
null mutant was avirulent in several animal models of infection.
Interestingly, Heimer et al. (194) demonstrated by reverse
transcription-PCR that vat was expressed in mice during ex-
perimental urinary tract infection; however, the contribution of
Vat to infection in this model was not reported.
Vat is encoded on a PAI which is inserted adjacent to the
thrW tRNA gene. The presence of vat at this position has been
demonstrated for uropathogenic E. coli strain CFT073 and the
neonatal meningitis strain E. coli RS218 (530; N. J. Parham
and I. R. Henderson, unpublished data). Interestingly, all of
these strains are associated with septicemia, suggesting that
Vat may be required for E. coli to enter or survive within the
bloodstream. Indeed, recent data have demonstrated the pres-
ence of Vat at a higher frequency in invasive strains of E. coli
than in strains isolated from patients with cystitis or intestinal
infections (Parham and Henderson, unpublished).
Others. Several other SPATE have been identified in a va-
riety of E. coli but have been subjected to only partial charac-
terization. Recently, Sandt and Hill (431) discovered a family
of four cell surface proteins (EibA and EibC to EibE) which
could bind IgG in a strain of E. coli (ECOR-9) isolated from a
healthy child. Further investigation revealed that these pro-
teins belonged to the type Vc class of secreted protein exem-
plified by YadA and Hia (see above). Further investigations
revealed that two of these genes (eibA and eibC) were linked to
genes encoding two SPATE proteins termed EaaA and EaaC,
respectively (431). Unfortunately, a function was not deter-
mined for these highly homologous proteins (99.4% identity);
however, because of their association with immunoglobulin-
binding proteins and their obvious homology to the IgA1 pro-
teases, it is tempting to speculate that they play a role in
degradation of the bound immunoglobulins.
Interestingly, in two different studies members of the
SPATE family were found to be associated with unique viru-
lence factors of LEE-negative STEC. Thus, Schmidt et al.
(440) identified EspI on a chromosomal PAI inserted at the
selC tRNA locus in E. coli O91:H strain 4797/97 and Leyton
et al. (284) identified EpeA on the large virulence plasmid of
E. coli O113:H21 strain EH41. It is worth noting that EspI
described by Schmidt et al. (440) is distinct from the type III
secreted effector molecule of the same name which was re-
cently described by Mundy et al. (344) in Citrobacter rodentium.
Both EspI and EpeA were assessed by in vitro assays for
functional activity. Schmidt et al. (440) revealed that EspI did
not degrade high-density or low-density lipoproteins, IgA1,
hemoglobin, haptoglobin, 2-macroglobulin, thrombin, lacto-
ferrin, transferrin, bovine serum albumin, or collagen type 3.
However, purified EspI could degrade pepsin, and this activity
could be inhibited by PMSF. Furthermore, coincubation of
human plasma with purified EspI revealed that it was capable
of degrading apolipoprotein A-I. EspI demonstrates a high
level of homology to EpeA (58% identity) (284). EpeA and
EspI were unable to induce cytopathic effects on HeLa cells
even after prolonged incubation (284). In vitro assays for pro-
tein function illustrated that, like Pic, EpeA could act as a
mucinase and possessed the ability to degrade gelatin and
pepsin. Further investigations are needed to fully assess the
with red. Note the perinuclear localization of Pet or Pet S260I inside the cells. (C and D) Effect of Pet (C) or Pet S260I (D) on fodrin redistribution
in HEp-2 cells. HEp-2 cells were treated with either Pet or Pet S260I for 3 h. The actin cytoskeleton is labeled with blue, Pet or Pet S260I is labeled
with red, and fodrin is labeled with green. Note that Pet but not Pet S260I causes cytoskeletal damage and fodrin redistribution (arrows), and it
is possible to detect a delayed interaction between Pet S260I and fodrin due to inability to cleave it (yellow dots). (E and F) Scanning electron
photomicrographs of in vitro-cultured human colonic tissues infected with the EAEC strain 042 (E) and the pet mutant strain J1F1 (F). For the
tissue shown in panel E, the surface of the colon is markedly abnormal, as manifested by increased crypt apertures (white arrowhead), prominent
mucosal crevices (white arrow), goblet cell pitting (black arrowhead in a circle), and rounding of epithelial cells (black arrow in a circle).
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contribution of EspI and EpeA to the pathogenesis of LEE-
negative STEC.
Recently, a second autotransporter of ETEC (EatA) was
described (385). In vitro studies demonstrated that EatA pos-
sesses the same specificity as SepA for p-nitroanilide-conju-
gated oligopeptides, cleaving peptides which have been iden-
tified as substrates for cathepsin G. Site-directed mutagenesis
of the residues within the predicted serine protease catalytic
triad abolished the ability of EatA to cleave the oligopeptides.
Comparison of the parent strain with an isogenic eatA mutant,
in the in vivo rabbit ileal loop model of infection, indicated that
there were no differences at 16 h postinfection in the fluid
accumulation elicited by each strain. In contrast, fluid accumu-
lation was not as pronounced with the eatA mutant at 7 h
postinfection compared to that for the wild type, even though
similar numbers of bacteria could be recovered from the loops,
indicating that the differences were not due to bacterial num-
bers or an altered survival rate. Furthermore, at 7 h postinfec-
tion the eatA mutant did not demonstrate foci of mucosal
destruction and leukocyte infiltration characteristic of the wild-
type organism (385). These data suggest that while EatA is
not absolutely required for infection, it may act to accelerate
ETEC virulence.
CLUSTER 6: BORDETELLA AUTOTRANSPORTERS
The genus Bordetella, which belongs to the -subclass of the
Proteobacteria, is composed of eight species: B. pertussis,
B. parapertussis, B. bronchiseptica, B. avium, B. holmesii,
B. hinzii, B. trematum, and B. petrii (515). With the exception
of B. petrii, all are associated with colonization or infection of
humans, animals, or birds (158). B. pertussis, B. parapertussis,
and B. bronchiseptica are the best characterized and the most
closely related phylogenetically, and it has been suggested that
they be considered subspecies instead of separate species (80,
158, 505). Each of the three subspecies is associated with re-
spiratory infections. B. pertussis is a highly contagious human
pathogen, the etiologic agent of whooping cough. B. para-
pertussis causes a similar illness in humans, albeit in smaller
numbers, and certain strains infect only sheep (505, 542). B.
bronchiseptica colonizes a variety of mammals and can, given
appropriate circumstances, cause kennel cough, atrophic rhi-
nitis, and bronchopneumonia in dogs, pigs, and rabbits, respec-
tively (80). B. bronchiseptica infections in humans occur rarely.
Details on Bordetella virulence factors, their regulation, and
their role in pathogenesis have been recently reviewed (80,
238, 298). In general, successful colonization and infection is
dependent on the production of an array of adhesins and toxins
which are regulated by a histidine kinase system called Bvg (79,
529). Included in this arsenal are several autotransporter pro-
teins. Only a handful of the Bordetella autotransporters have
been functionally characterized to date. In terms of Bvg regu-
lation, brkA, prn (pertactin), sphb1, tcf, and vag8 are positively
regulated by Bvg whereas bapA, phg, sphb2, and sphb3 are
unaffected by the Bvg system (12, 298).
Identification of Autotransporters in the Bordetella Genomes
The sequencing and comparative analyses of the genomes of
B. pertussis strain Tohama I, B. parapertussis strain 12822, and
B. bronchiseptica strain RB50 (382) have provided a unique
opportunity to examine the genomes of these closely related
subspecies for their complement of autotransporters. Analysis
of these genomes has uncovered an inventory of 22 known or
putative autotransporter proteins (Table 2). These include per-
tactin (47, 61), BrkA (132, 133), Tcf (141), Vag8 (140), Phg
(accession number AJ009835), and SphB1 (82), as well as a
number of previously identified but as yet uncharacterized
proteins (382) and nine novel putative autotransporters includ-
ing a putative adhesin and a putative lipase (Table 2). While
most of the autotransporter ORFs are intact, some are pseu-
dogenes and still others are absent altogether in one or more
of the strains analyzed. Thus, these strains of B. pertussis,
B. parapertussis, and B. bronchiseptica have the capacity to
express 12, 16, and 20 putative functional autotransporters,
respectively. The dozen pseudogenes present in the three
strains have resulted from mutations producing frameshifts
and an in-frame stop codon, and by disruption by the insertion
elements IS481 and IS1001 (Table 2). Frameshift mutations
found in brkA and tcf, and the absence of tcf in B. parapertussis,
probably explain why they have eluded detection in B. para-
pertussis and B. bronchiseptica in previous studies (141; S.
Pleasance and R. C. Fernandez, unpublished data). However,
not all mutations result in pseudogenes. For example, approx-
imately one-quarter of the passenger domain of BatB is de-
leted in B. parapertussis.
There are three examples of ORFs encoding autotransport-
ers in tandem. While BPP0449/BB0450 has overall high se-
quence identity to BPP0452/BB0452 (batB), suggesting a gene
duplication, BPP1617/BB3111 and BPP1618/BB3110 found in
tandem have highly similar translocating units but with differ-
ent passenger domains. This is also seen with tcf (BB3291) and
bapB (BB3292). Interestingly, the translocating units of tcf,
bapB, BPP1617/BB3111, and BPP1618/BB3110 are all highly
homologous.
One ORF (BP0775/BPP0337/BB0340) may encode a pas-
sengerless translocator; however, two additional amino acids
are present following the canonical terminal aromatic amino
acid present in autotransporters, and the putative signal se-
quence, which is predicted with low probability, is more rem-
iniscent of a linker region. Thus, it remains to be determined
whether this is a bona fide autotransporter. Of the proteins
whose predicted translated product includes the -domain,
BapA, BPP0822/BB0916, BPP2975/BB2941, and BPP0449/
BB0450 are weakly predicted to have signal sequences (Table
2), and it remains to be seen whether they are surface ex-
pressed. Although SphB1 does not have a predicted signal
peptidase I cleavage site, it has a lipoprotein consensus se-
quence and recently has been shown to be a lipoprotein (83;
see above). The predicted signal sequences of the rest of the
autotransporters range in size from 30 to 54 amino acids, in
keeping with the general theme of unusually long signal se-
quences in autotransporter proteins.
Phylogenetic analyses of the amino acid sequences of the
-domains of the Bordetella autotransporters have suggested
that they fall into three primary groups, designated 1, 2, and 3,
that correspond to the function of their passenger domains
(Pleasance and R. Fernandez, unpublished). Half of the pro-
teins are found in cluster 1, and this group includes pertactin,
BrkA, Tcf, and Vag8. A group of proteins that appear to be
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adhesins related to the E. coli AIDA-I (25) autotransporter are
found within group 2, and known or predicted proteases are
segregated in group 3. Phg, BapA, and SphB1 appear to be
outliers within groups 1, 2, and 3, respectively (Fig. 10). The
one exception to this classification is BP2627/BPP1256/
BB2324, which most closely resembles conserved ORFs in
A. tumefaciens and Chlamydophila pneumoniae.
Pertactin
The archetypal Bordetella autotransporter is pertactin (47,
61). Pertactin was implicated as an adhesin when Chinese
hamster ovary (CHO) and HeLa cells were used as the exper-
imental system (278), but a direct role for pertactin-mediated
adherence has not been observed in human bronchial (NC1-
H292) and laryngeal (HEp-2) epithelial cell lines (418, 502).
Still, pertactin is an important component of the current acel-
lular pertussis vaccines (65, 209, 468), even though its exact
role in pathogenesis remains to be definitively defined. Pertac-
tin, formerly called P.69, is synthesized as a 93-kDa precursor
in B. pertussis. Following cleavage of a 34-amino-acid signal
sequence, pertactin is processed after amino acid 597 to yield
a passenger domain of 60.3 kDa that migrates as a 69-kDa
protein on SDS-polyacrylamide gels. Additional processing can
occur after amino acid 577 to produce a 67-kDa passenger
domain (61). The protease responsible for cleavage of the
passenger moiety from the -domain has not been identified.
Although it is cleaved, the pertactin passenger remains as-
sociated with the bacterial surface in a manner analogous to
antigen 43 and AIDA-I (see above).
The crystal structure of the passenger domain of pertactin
(1DAB) has been solved to 2.5 A˚ (123) and comprises a right-
handed three-strand parallel  helix that adopts a kidney or
“V” shape in cross-section (Fig. 11). Typically, the three
-strands in parallel -helix proteins are designated PB1, PB2,
and PB3 and are separated by T1, T2, and T3 turns (227).
Unlike the T2 turn at the base of the “V,” the T1 and T3 turns
are heterogeneous in size. In the -helix structure, PB1 forms
the indentation in the “V.” This groove is the site where other
-helix structures (e.g., the tail spike protein of phage P22)
interact with their cognate substrates (462). No such interac-
tions have been noted for pertactin; it is possible that the large
T1 loop of pertactin (Arg260-Gly294) may occlude this site (123,
227). Indeed, the only domain in pertactin thus far associated
with adherence is the RGD motif found in the T1 loop (278).
This T1 loop comprises a proline-rich repeat, GGXXP5, des-
ignated “region 1,” which is polymorphic in different clinical
isolates and vaccine strains (336). Antibodies to this region
have been found in patients with pertussis and are associated
TABLE 2. Bordetella autotransporter proteins
Known
or predicted
Bordetella auto-
transporter
ORF designation and no. of residuesa
Accession
no.b
Reference(s) or
best BLAST hit
of passenger
Bvg reg-
ulationc
Known
(predicted)
signal peptided
Notable
motifse
Bp Bpa Bb
Pertactin BP1054, 910 BPP1150, 922 BB1366, 916 P14283 47, 61  34 RGD (2)
BrkA BP3494, 1,010 BPP0867, (173) BB0961, (127) AAA51646 132  42 RGD (2)
SphB1f BP0216, 1,039 BPP0417, 1,043 BB0419, 1,039 CAC44081 82, 83  No Serine protease,
lipoprotein
Tcf BP1201, 647 BB3291, (145) CAA08832 141  (39) RGD
Vag8 BP2315, 915 BPP2415, 915 BB1864, 915 AAC31247 140  37 RGD
Phg BP1767, 418 BPP1998, 415 BB2246, 415 CAB38010 None 0 (35) None
SphB2 BP1660, 1,024 BPP2745, (193) BB2741, 1,025 12 0 (37) None
SphB3 BP1110, 1,076 BPP2053, 1,076 BB2301, 1,076 12 0 (29) Thiol protease
BapA (AidB)g BP2224, 903 BPP2251, (295) [I] BB1649, 903 CAC14165 AIDA-1 0 (30)h None
BapB BP1200, (119) [I] BPP1815, 605 BB3292, 613 CAC14166i None ND (41) None
BapC (BatE)g BP2738, (102) BPP2591, (100) BB2033, 998 CAC14167 Pertactin ND (45) RGD (2)
BatA BP1793, (53) [I] BPP2022, 538 BB2270, 536 None ND (33) None
BatB BP0529, 2,300 BPP0452, 1,769 BB0452, 2,300 ShdA ND (38) RGD (2), P-loop,
aspartyl protease
Novel BP0775, 340 BPP0337, 340 BB0340, 340 None ND ? None
Novel BP1344, 866 BPP2678, (717) BB2830, 866 Ag43, AIDA-1,
BapA
ND (36) RGD (2)
Novel BP1610, (124) BPP2975, 937 BB2941, 937 Pertactin ND 32h None
Novel BPP1617, 491 BB3111, 497 None ND (33) None
Novel BPP0449, 1,616 BB0450, 2,152 ShdA ND (40)h P-loop, lipase
Novel BPP0735, 996 BB0821, 999 YapE ND (30) RGD
Novel BPP0822, 1,196 BB0916, 1,196 SSP-h1 ND (23)h RGD
Novel BPP1618, 519 BB3110, 705 Tcf ND BP1618 (33),
BB3110 (54)
None
Novel BP2627, (178) BPP1256, 718 BB2324, 718 (34) Lipoprotein
a ORF designation refers to genome sequence annotation. Bp, B. pertussis; Bpa, B. parapertussis; Bb, B. bronchiseptica. ORFs in bold type have been analyzed. When
the number of amino acid residues is in parentheses, the ORF is truncated due to frameshift or insertion of a stop codon. Disruption by an insertion element is indicated
by [I].
b GenBank accession number, if known.
c Regulation by the Bvg two-component system. , activated genes; 0, not activated; ND, not determined.
d Values represent numbers of amino acids in the signal sequence; values in parentheses are derived from predictions based on SignalP (http://www.cbs.dtu.dk
/services/SignalP-2.0/).
e Based on PROSITE patterns (http://ca.expasy.org/prosite/).
f Number of residues does not match the genome annotation.
g Alternate name for this putative autotransporter.
h Weakly predicted.
i Accession number annotation does not take into account the presence of the insertion element.
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with protection in an animal model (246). The passenger do-
main of pertactin is the largest -helix described to date, hav-
ing 16 rungs or coils. Stacking of internal residues is a defining
feature of -helix proteins, and in pertactin the stacks are
composed of aliphatic residues and are quite striking (123).
Toward the C terminus of pertactin, the -helix structure
changes to a two-strand -roll with internal aromatic stacks.
The -roll then returns to a three-strand structure, which leads
into a -sandwich. As noted by Jenkins and Pickersgill (227),
the -helix structure of pertactin is capped by a -hairpin at its
C terminus. Val472-Leu566, which comprises the C-terminal
region of this pertactin structure, is conserved in several auto-
transporters and promotes folding of the passenger domain in
a related autotransporter, BrkA (351). Not evident in the per-
tactin structure (1DAB) is the second proline-rich region (PQP5)
that follows the -hairpin. This region is associated with elic-
iting protective immunity in a mouse aerosol model (62).
A recent report (293) has implicated pertactin as the major
tropism determinant for the newly described B. bronchiseptica
Bvg-plus tropic phage BPP-1. BPP-1 does not plaque efficiently
on bvg or prn (pertactin) mutants of B. bronchiseptica but can
do so if pertactin is expressed either under the usual Bvg-plus
conditions or ectopically in a Bvg-minus background. The
BPP-1 phage can switch tropism by using a Bordetella reverse
transcriptase (Brt) mechanism that transcribes mutated copies
of the major tropism determinant (Mtd) protein, a protein
associated with tail fiber formation. For example, the BMP-1
phage is specific for Bvg-minus cells by virtue of a mutated Mtd
protein. Similarly, the BIP-1 phage infects Bvg-plus and -minus
bacteria indiscriminately. The receptors for BMP-1 and BIP-1
have not been determined.
BrkA, TcfA, and Vag8
BrkA protects B. pertussis from killing by the classical com-
plement pathway (132). Although the mechanism of protection
has not been elucidated, BrkA acts at an early step in the
complement activation pathway (19), possibly by recruiting a
complement resistance factor present in serum (133). How-
ever, a recent study demonstrated that anti-BrkA antibodies
could boost the existing bactericidal capacity of human serum
against B. pertussis by neutralizing the activity of BrkA (363).
BrkA also plays a role in adherence, since mutants with mu-
tations in BrkA bind less efficiently to epithelial (HeLa) and
fibroblast (MRC-5) cell lines (127, 132). Previous 50% lethal-
dose studies have shown that a brkA mutant was impaired in its
capacity to kill infant mice (528), showing that BrkA is an
important B. pertussis virulence factor. BrkA is synthesized as
a 103-kDa protein that is processed into a 73-kDa passenger
domain and a 30-kDa -domain. N-terminal sequencing of the
73-kDa passenger domain has determined the signal sequence
to be 42 amino acids long (364). Cleavage of BrkA after amino
acid 731 yields the outer membrane-resident -domain (187).
Although having a function distinct from pertactin, BrkA has
28% sequence identity to pertactin over its passenger domain
and 54% identity over the -domain (132). Like pertactin, the
73-kDa passenger of BrkA is often seen as a doublet (132,
171). Since it has sequence identity to pertactin at the amino
FIG. 10. Phylogenetic relationships of the transporter domains of known and predicted B. bronchiseptica autotransporters. The predicted
transporter domains of B. bronchiseptica autotransporters were aligned using CLUSTALW and subjected to distance matrix and neighbor-joining
methods by using the PHYLIP package. The resulting phylogenetic tree was visualized with TreeView. Bootstrap values are for 100 replicates.
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acid residues comprising the processing sites of pertactin, it is
likely that BrkA is processed similarly, although the protease
has yet to be identified. Processed BrkA is steadfastly associ-
ated with the bacterial surface.
Tcf (tracheal colonization factor) is a proline-, glycine-, and
serine-rich protein that, although predicted to be a 68-kDa
protein, migrates at 90 kDa on SDS-polyacrylamide gels (141).
It is predicted to have a 39-amino-acid signal sequence and can
be found both associated with the bacterial cell surface and as
a secreted protein. Tcf mutants have a 10-fold-reduced capac-
ity for tracheal colonization as measured in a mouse aerosol
model. The mechanisms, contributing to the colonization
properties of Tcf have not been elucidated; however, an RGD
motif might suggest a role in adherence.
Vag8 is a somewhat unusual Bordetella autotransporter. Un-
like the other characterized Bordetella autotransporters, Vag8
is not cleaved away from its -domain. Vag8 is a 95-kDa pro-
tein that has a 37-amino-acid signal sequence (187). Despite its
similarity to pertactin, Tcf, and BrkA, a phenotype attributed
to virulence has yet to be associated with Vag8 (140).
CLUSTER 7: CHLAMYDIAL AUTOTRANSPORTERS
Members of the Chlamydiaceae are obligate intracellular
pathogens that replicate within membrane-bound vacuoles.
The recent completion of five chlamydial genome sequences
has led to the division of the Chlamydiaceae into two genera;
Chlamydia (Chlamydia trachomatis, Chlamydia suis, and Chla-
mydia muridarum), and Chlamydophila (Chlamydophila pneu-
moniae, Chlamydophila abortus, Chlamydophila psittaci,
Chlamydophila pecorum, Chlamydophila felis, and Chlamy-
dophila caviae) (77, 126). However, despite these phylogenetic
differences, all the species demonstrate commonalities in their
life cycles, virulence traits, and modes of host and tissue tro-
pism (77, 186, 469). Indeed, all members of the Chlamydiaceae
possess a developmental life cycle that alternates between the
infectious extracellular form termed the elementary body (EB)
and the metabolically active form termed the reticulate body
(RB); the EB develops into the RB after infection (186). Fur-
thermore, examination of the completed genomes revealed the
existence of a family of genes encoding polymorphic outer mem-
brane proteins (POMPs), which are unequally distributed
throughout the different species. Recent evidence has dem-
onstrated that these proteins are secreted via the autotrans-
porter pathway (198). Thus, Chlamydiaceae is the only family
of bacteria outside of the Proteobacteriaceae known to possess
autotransporters.
Although the POMPs are widespread and numerous (C. tra-
chomatis possesses 21 pomp genes), a definitive function for
these proteins remains to be determined. However, several
lines of investigation suggest that these proteins play a role in
virulence. First, several investigations of different organisms
have demonstrated that the extracellular infective form, the
EB, expresses POMPs during the infective process (173, 387,
483, 501). In silico analyses demonstrated that these POMPS
FIG. 11. Crystal structure of the B. pertussis protein pertactin. The structure of pertactin was solved to a resolution of 2.5 A˚ (123). (A) Side view
of pertactin, with the N terminus located to the top. (B) End view of pertactin looking from the N terminus toward the C terminus. This protein
consists of 16 parallel -strands arranged in a left-handed helix from which several loops extend. T1, T2, and T3 represent the turns between the
three strands of the -helix. The RGD motif is shown in purple in T1. The region in blue represents a conserved region that is present in many
autotransporters and has been shown to mediate folding of the passenger domain (351). This is the largest -helix known. Structurally, this
molecule is related to the tail spike proteins of P22 phage and to the pectin lyases and methylesterases (227). Adapted from reference 123 and
the Protein Data Bank (30).
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are homologous to the adhesins AIDA-I and filamentous
haemagglutinin (see above) and, like these adhesins, possess
internal repetitive amino acid sequences (198). Indeed, Vretou
et al. (519) provided some recent evidence to suggest that the
passenger domains of the POMPs exist as a -helix pyramid,
similar to the structure of the pertactin autotransporter pro-
tein. Several of these proteins also possess functional motifs
associated with virulence, including the RGD cell attachment
sequence and the subtilase serine protease motif, both of which
are associated with the functions of several autotransporter
proteins (see above). Furthermore, recent investigations have
also demonstrated that, like the E. coli AIDA-I and TibA
adhesins, several of the POMPs are glycosylated (520). In
AIDA-I and TibA, this glycosylation is required for the adhe-
sive ability of the molecule. Such data suggest that the EB
expresses the POMPs to allow entry into the host cell. Indeed,
recent evidence demonstrated that antibodies against the C.
pneumoniae PmpD protein blocked the ability of EBs to infect
tissue culture cells (527).
Recently, Rocha et al. have demonstrated that several of
these POMPs undergo reversible phase variation by slipped-
strand mispairing (420). Phase variation has been demonstrat-
ed for immunogenic surface proteins throughout the Proteo-
bacteriaeceae and has been noted for several autotransporter
proteins including the neisserial AspA/NalP protein and anti-
gen 43 from the AIDA-I family of autotransporters (see
above). Moreover, examination of the role of the POMPs in
triggering an immune response recently demonstrated that
Pmp20 and Pmp21 from C. pneumoniae could increase the
production of the inflammatory mediators IL-6, IL-8 and
monocyte chemoattractant protein 1 in a dose-dependent fash-
ion in cultured human endothelial cells. Furthermore, this
induction was due to the activation of the nuclear factor B
pathway (353). It was suggested that by interaction of the
POMPs with the endothelium, the POMPs contribute to vas-
cular injury and thus to the development and progression of
atherosclerotic lesions, which are associated with infection by
several organisms from the Chlamydiaceae. No doubt the true
function of the autotransporter POMPs will be revealed by
future investigations.
CLUSTER 9: RICKETTSIAL AUTOTRANSPORTERS
Rickettsiae are obligate intracellular organisms that infect
arthropods and vertebrates, causing typhus and spotted fevers
in humans. The spotted fever group rickettsiae are further
differentiated from the typhus group by the presence of 190-
and 120-kDa outer membrane proteins called rickettsial outer
membrane proteins rOmpA and rOmpB, respectively.
The rOmpB protein of R. rickettsii is encoded by a gene with
the capacity to code for a protein of about 168 kDa (163).
However, like other autotransporters, a polypeptide of this size
is not detected on purified rickettsiae; indeed, N-terminal se-
quencing of a 32-kDa, heat-modifiable outer membrane pro-
tein revealed that it is encoded by the 3 end of the rompB
gene, suggesting that the rOmpB protein is processed from a
large precursor to yield the mature 120-kDa rOmpB protein
and the 32-kDa peptide, which remain noncovalently associ-
ated (163). The rompA gene sequence predicts a 217-kDa
protein, with a unique pattern of 13 tandemly repeated units of
72 to 75 amino acids each in the N-terminal end of the protein
and greater than 75% identity between repeat units (10).
rOmpB does not possess any sequence similarity to the amino
acid repeats found in the rOmpA protein; however, rOmpA
and rOmpB do show homology within their respective C-ter-
minal 320 amino acids (	36% identity), a region that may
include a membrane anchor in the last 10 amino acids of each
protein (181, 403).
rOmpA is a minor constituent of the rickettsial cell surface,
but important biological functions have been demonstrated or
implicated for similar repeat domains in proteins of other
prokaryotes and eukaryotes, such as antigenic structure or
variation, opsonic properties, carbohydrate- and other ligand-
binding activities, and organelle structure. For rOmpA from
R. rickettsii, a monoclonal antibody to this region is protective
against experimental infection. In addition, recombinant
rOmpA antigen serves as an effective immunogen in mice and
guinea pigs challenged with virulent R. rickettsii (322). The
repeat unit domain has been hypothesized to be involved in
rickettsial adhesion (286, 496). The length of the repeat re-
gions is variable among species of spotted fever group rickett-
siae (145) and has been used extensively in an effort to deter-
mine the evolutionary status of the spotted fever group of
Rickettsiales (418, 424, 532).
The rOmpB protein is the most abundant surface protein on
rickettsiae, and it is interesting because of its surface localiza-
tion, strong immunogenicity, and reactivity with monoclonal
antibodies that protect mice against lethal rickettsial challenge
(9). Antigenically, rOmpB displays species- and serotype-spe-
cific antigenic properties but also displays group- and genus-
specific activity (9). Ultrastructural analyses of the rickettsial
outer membrane have been interpreted as evidence for a
paracrystalline surface array, or S layer, on rickettsiae (457).
Immunization with native rOmpB of R. typhi completely pro-
tects mice (90) and partially protects guinea pigs (43) against a
lethal dose of R. typhi.
Recently, Dı´az-Montero et al. (105) have shown that im-
munization with each of three fragments (rompA4999–6710,
rompB1550–2738, and rompB2459–4123) conferred a degree of
protection on immunized mice against virulent rickettsial chal-
lenge. Protection was achieved when DNA immunizations
were followed by booster immunizations with the homologous
recombinant protein. Proliferation and gamma interferon se-
cretion were detected after in vitro stimulation of lymphocytes
from immunized animals with whole R. conorii antigen.
CLUSTER 10: LIPASES AND ESTERASES
EstA
Pseudomonas aeruginosa is a soil bacterium that is an im-
portant opportunistic human pathogen which secretes a variety
of proteins into the extracellular medium. Three of these are
lipolytic enzymes, including two extracellular phospholipase C
proteins and a lipase (222). Lipases are carboxylesterases that
have the ability to hydrolyze long-chain acylglycerols, whereas
esterases hydrolyze ester substrates with short-chain fatty ac-
ids. However, it should be emphasized that lipases are per-
fectly capable of hydrolysing esterase substrates. Wilhelm et al.
found that a lipase-negative deletion mutant of P. aeruginosa
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PAO1 still showed extracellular lipolytic activity toward short-
chain p-nitrophenylesters (533). The sequence responsible for
this phenotype revealed an ORF of 1,941 bp, encoding an
esterase EstA. The product of estA is a 69.5-kDa protein, which
possesses all the features of an autotransporter protein. Ex-
pression of estA in P. aeruginosa and E. coli and subsequent cell
fractionation revealed that the enzyme was associated with the
cellular membranes and can be released by trypsin treatment.
These data indicate that the enzyme is located in the outer
membrane serine and the esterase/lipase catalytic domain is
exposed to the surface (533). This catalytic site is characterized
by the consensus motif GDSL, where S represents the active
serine residue. In fact, the absolute esterase activity was about
10-fold higher in the overexpressing strain, but in both strains
more than 95% of the esterase activity was detected in the
crude membrane fraction.
ApeE
Interestingly, the estA gene showed high similarity to apeE
encoding an outer membrane esterase from S. enterica serovar
Typhimurium (58) and to lip-1 encoding a lipase from Xeno-
rhabdus (Photorhabdus) luminescens (523), both of which are
putative autotransporter proteins. Mutations at the apeA (now
designated tesA) locus of S. enterica serovar Typhimurium lead
to loss of a periplasmic enzyme originally identified by its abil-
ity to hydrolyze the chromogenic substrate N-acetylphenylala-
nine -naphthyl ester (NAPNE) (327). However, isolation of
pseudorevertants with the ability to hydrolyze NAPNE led to
the identification of mutations in the apeR locus, which en-
codes a negative regulator of the transcription of the mem-
brane hydrolase ApeE (70). The predicted product of apeE is
a 69.9-kDa protein, which is processed to a 67-kDa species by
removal of a signal sequence (25 amino acid residues). Amino
acid sequence analysis of ApeE indicates that, like EstA, it is a
member of the GDSL family of serine esterases/lipases. The
Salmonella esterase catalyzes the hydrolysis of variety of fatty
acid naphthyl esters and of C6 to C16 fatty acid p-nitrophenyl
esters but not peptide bonds (58). Interestingly, one method
for identifying Salmonella spp. in the clinical laboratory in-
volves the use of methyl umbelliferyl caprylate (MUCAP), a
substrate that fluoresces on hydrolysis of the ester bond (1),
and the apeE gene product is the enzyme in Salmonella unique-
ly responsible for the hydrolysis of this substrate (58). Re-
cently, it has been found that mutations in apeR, the regulatory
locus of apeE, affect the pstSCAB-phoU high-affinity phosphate
transport operon. Furthermore, expression of apeE was in-
duced by phosphate limitation, and this induction required the
phoBR phosphate regulatory system (71).
Lip-1
ApeE is most similar to a lipase secreted by the entomo-
pathogenic bacterium Photorhabdus luminescens. The P. lumi-
nescens Lip-1 lipase is able to hydrolyze Tween 80, a water-
soluble oleic acid ester of a polyoxyalkylene derivative of
sorbitan (523). In fact, ApeE cleaves Tween 80 but not as
efficiently as Lip-1 does. This could be due to a lower activity
against this substrate or to the difference in localization of the
two enzymes; Lip-1 is secreted into the culture medium, where-
as ApeE activity is membrane bound (58). The lip-1 sequence
revealed a translation product of 645 amino acids, from which
a hydrophobic signal sequence of 24 amino acids is removed
during processing, and a -domain consistent with an auto-
transporter mode of secretion. Furthermore, the lipase gene
was cloned from P. luminescens on the basis of the activity of
the gene product on Tween 80, p-nitrophenylpalmitate, and
naphthyl acetate. The gene was efficiently expressed in E. coli
under the control of its own promoter (523).
McaP
A recent report described the identification, using a plasmid
library and transposon mutagenesis-based approach, of a novel
adhesin (McaP) in M. catarrhalis (489). Sequence analysis re-
vealed that McaP was a member of the GDSL family of lipases/
esterases and had all the hallmarks of an autotransporter pro-
tein. Investigation of enzymatic activity revealed that McaP
was an esterase and was capable of cleaving phosphatidylcho-
line and lysophosphatidylcholine in a manner analogous to the
Moraxella bovis phopholipase B. Interestingly, McaP displayed
activity toward tributyrin, a substance which is used diagnosti-
cally to differentiate between M. catarrhalis and Neisseria spp.
Surprisingly, expression of the gene product in E. coli in-
creased adherence to a range of epithelial cells in vitro (489).
Thus, the precise role of this protein in mediating disease or
colonization of the host remains to be determined. Interest-
ingly, the other major adhesins of M. catarrhalis include UspA1,
UspA2, and Hag, which all appear to be members of the type
Vc family of proteins (73, 210, 273, 386).
OTHER AUTOTRANSPORTER PROTEINS
Adhesins
In a recent report, Rose et al. (423) described an in silico
analysis of the Actinobacillus actinomycetemcomitans genome
for the presence of autotransporters. Using this approach,
these researchers identified Aae, which demonstrated C-ter-
minal homology to H. influenzae Hap adhesin. However, the
N-terminal passenger domain did not possess significant ho-
mology to any proteins listed in GenBank. Sequencing of the
gene from several isolates revealed allelic diversity that was
dependent on the presence of amino acid repeats located with-
in the passenger domain. A null aae mutant showed a marked
reduction in adherence to KB cells, suggesting a role in adhe-
sion. In agreement with a role for Aae in adhesion, Rose et al.
(423) were able to demonstrate a specific interaction between
the Aae protein and epithelial cells. Like the Hap autotrans-
porter protein, Aae is cleaved on the bacterial cell surface by
the action of lactoferrin. These results were compatible with
previous investigations which demonstrated that lactoferrin
decreased the efficiency of A. actinomycetemcomitans adhesion
to fibroblasts and basement membrane proteins (8, 134).
The advent of genome sequencing has revealed many po-
tential virulence factors from a variety of bacterial sources.
Perhaps some of the most widespread homologous virulence
determinants are the putative autotransporter adhesin mole-
cules, the vast majority of which remain uncharacterized. These
molecules have been found across the Proteobacteriaceae, in-
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cluding human pathogens such as Y. pestis (383) and plant
pathogens such as Xylella fastidiosa (456). A recent report
described the existence of a putative autotransporter adhesin
in the animal pathogen Mannheimia haemolytica (296) which
was recognized by antisera to the H. influenzae HMW1 protein;
HMW1 is secreted by the two-partner pathway. However, a
definitive function was not ascribed to this secreted protein.
A family of previously uncharacterized autotransporter pro-
teins in Bartonella spp. (Iba, for “inducible Bartonella auto-
transporter”) were recently described (447). Bartonella spp.
establish a hemotropic infection in mammals. After initial in-
fection, the bacteria are cleared from the bloodstream but
survive in an as yet undetermined primary niche. From this
niche, the bloodstream in synchronously seeded with bacteria
every 4 to 5 days. These bacteria adhere to and subsequently
invade mature erythrocytes. Using differential fluorescence in-
duction, Seubert et al. (447) demonstrated that transcription of
the Iba family of autotransporters was up regulated during en-
dothelial infection in vitro. Interestingly, using an animal mod-
el of Bartonella infection, at least one gene (ibaB) was shown to
be fully activated at the onset of hemotropic infection but im-
mediately down regulated after erythrocyte invasion, sug-
gesting a role for this protein in adhering to the erythrocyte.
However, definitive functions for these proteins remain to
be determined.
Other descriptions of autotransporters involved in adhesion
can be divined from global mutagenesis, proteomic, and tran-
scriptomic studies. Thus, it appears that A. tumefaciens pos-
sesses an essential autotransporter adhesin that remains un-
characterized (235), P. aeruginosa possesses an autotransporter
that contributes to Caenorhabditis elegans killing and Arabidop-
sis leaf colonization (482), and M. catarrhalis possesses an auto-
transporter, McaP, which appears to play a dual role as a lipase
and an adhesin (489; see above).
Sialidases
P. multocida is a mucosal pathogen and a normal inhabitant
of upper respiratory systems of many animals, is commonly a
secondary pathogen in upper respiratory infections, and is a
common cause of human soft tissue infections that result from
animal bites. Most isolates of P. multocida produce sialidase
activity (110), which may contribute to colonization of the
respiratory tract (492) or the production of lesions in an active
infection (164). Mizan et al. (329) cloned and sequenced a
sialidase gene, nanH, from a fowl cholera isolate of P. multo-
cida. NanH (80 kDa) exhibited significant amino acid sequence
homology to many microbial sialidases. However, insertional
inactivation of nanH resulted in a mutant strain that was not
deficient in sialidase production but exhibited reduced enzyme
activity and growth rate on 2,3-sialyllactose compared with the
wild type. As a result, the authors identified a second gene,
which differed from nanH in DNA sequence and substrate
specificity but possessed sialidase activity. The derived amino
acid sequence of a 3,210-bp ORF contained an N-terminal
signal sequence, exhibited homology to sialidase proteins, and
demonstrated all the hallmarks of an autotransporter. Since
the DNA sequence showed no significant homology (20%) to
the nanH gene, this sialidase gene was designated nanB, NanB
is a 120-kDa protein. The sialidase domain resided within the
N-terminal 510 amino acids, which exhibited approximately
50% homology to Streptococcus pneumoniae NanA and the
large clostridial sialidase proteins, suggesting that NanB be-
longs to the large sialidase family. NanB contained a FRIP
motif and four aspartate boxes, which are expected sialidase
motifs. This group of sialidases, however, appeared not to con-
tain the conserved tryptophan residues expected to occupy the
hydrophobic pocket of the active enzyme (329). Nevertheless,
NanB demonstrated activity on both 2,3- and 2,6-sialyllac-
tose, while NanH demonstrated activity only on 2,3-sialyllac-
tose. Neither enzyme liberated sialic acid from colominic acid
(2,8-sialyllactose). Recombinant E. coli containing the siali-
dase genes was able to utilize several sialoconjugants when
they were provided as sole carbon sources in minimal medium.
These data suggest that sialidases have a nutritional function
and may contribute to the ability of P. multocida to colonize
and persist on vertebrate mucosal surfaces (329).
FUTURE DIRECTIONS
Type V secretion systems are protein translocation machines
dedicated to the secretion of single specific bacterial effector
molecules. Since the initial description of the IgA1 proteases
over 15 years ago, little research has been invested in elucidat-
ing the secretion mechanism of these molecules. This has been
redressed in the last several years, with multiple groups study-
ing the details of the separate inner and outer membrane
translocation events. While some investigations appear to have
confirmed the initial model of secretion, others have cast doubt
on it, and thus several important questions about the structure
and function of the pathway remain to be answered. Does the
translocating unit remain as a monomer or oligomerize to form
a large central channel? Do the translocating units permit
translocation of the polypeptide through the -barrel, via a
large central channel, or through an alternative pathway?
What is the energy force driving the secretion of the passenger
domain? Are there accessory factors involved in periplasmic
transit and assembly into the outer membrane? What is the
nature of the factors involved in processing the proteins on the
cell surface? Are intrinsic factors, such as the autochaperone
domain, necessary for the secretion of all autotransporters? It
appears from the current research strategies of several labo-
ratories that the next few years will undoubtedly shed light on
these quandaries, permitting a fuller view of the secretion
mechanism and perhaps revealing novel variations on the type
V secretion theme.
The advent of genomics has spawned a new chapter in the
study of proteins secreted via the type V pathway. Determina-
tion of the genomic sequences has allowed a rapid expansion of
the family and has demonstrated that autotransporter proteins
represent the largest family of secreted polypeptides in gram-
negative bacteria. However, despite the identification of sev-
eral hundred autotransporter proteins through in silico analy-
ses, only a relatively small number have been characterized. It
is likely future investigations will reveal that many of these
proteins play essential roles in the pathogenesis of infectious
diseases. Nevertheless, the number of uncharacterized proteins
awaiting investigation will ensure plenty of opportunity for
research in decades to come.
Perhaps the most interesting facet of autotransporter re-
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search will be its application to therapeutics and biotech-
nology. Indeed, several passenger domains are candidates
for subunit or multicomponent vaccines. The incorporation
of these proteins into such vaccines is spurred on by the dem-
onstration that pertactin contributes to the protective effect of
the whooping cough vaccine (65). Indeed, Pizza et al. (394),
using a rational genomic approach to designing vaccines, iden-
tified NhhA as one of their candidate proteins for a meningo-
coccal vaccine. The seminal work on secretion has also dem-
onstrated the potential biotechnological exploitation of the
autotransporter secretion pathway, namely, by displaying het-
erologous proteins on the bacterial surface (453). The possible
applications of this autodisplay system are numerous and in-
clude (i) exposure of antigenic determinants for vaccine devel-
opment (142, 267, 316), (ii) expression of peptide libraries for
epitope mapping or antibody specificity test (258), (iii) display
of receptor or ligand for binding assays or purification (499,
500), (iv) functional domain analyses of a heterologous protein
(59, 499, 500), and (v) bioconversion by expressing enzymatic
activity on the bacterial surface (229, 230, 276). In conclusion,
further understanding of the autotransporter secretion path-
way and the functions of the passenger domains will facilitate
a richer view of the mechanisms and evolution of bacterial
pathogenesis and provide important practical applications for
the medical and biotechnological communities.
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